<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107688</article-id><article-id pub-id-type="doi">10.7554/eLife.107688</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107688.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Ω-Loop mutations control dynamics of the active site by modulating the hydrogen-bonding network in PDC-3 β-lactamase</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shuang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0005-4968-5869</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Mack</surname><given-names>Andrew R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hujer</surname><given-names>Andrea M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bethel</surname><given-names>Christopher R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bonomo</surname><given-names>Robert A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2650-2925</contrib-id><email>shozeb.haider@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vrybr67</institution-id><institution>Research Service, Louis Stokes Cleveland, Department of Veterans Affairs Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Medicine, Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vrybr67</institution-id><institution>Clinician Scientist Investigator, Louis Stokes Cleveland Department of Veterans Affairs Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Departments of Pharmacology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>UCL Centre for Advanced Research Computing</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yej8x59</institution-id><institution>University of Tabuk (PFSCBR)</institution></institution-wrap><addr-line><named-content content-type="city">Tabuk</named-content></addr-line><country>Saudi Arabia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Allen</surname><given-names>Toby W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ttjf776</institution-id><institution>RMIT University</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>01</month><year>2026</year></pub-date><volume>14</volume><elocation-id>RP107688</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-06-10"><day>10</day><month>06</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-05-14"><day>14</day><month>05</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.04.578824"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-09-25"><day>25</day><month>09</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107688.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-12-09"><day>09</day><month>12</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107688.2"/></event></pub-history><permissions><copyright-statement>© 2025, Chen et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Chen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107688-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-107688-figures-v2.pdf"/><abstract><p>The expression of antibiotic-inactivating enzymes, such as <italic>Pseudomonas</italic>-derived cephalosporinase-3 (PDC-3), is a major mechanism of intrinsic resistance in bacteria. Using reinforcement learning-driven molecular dynamics simulations and constant pH MD, we investigate how clinically observed mutations in the Ω-loop (at residues V211, G214, E219, and Y221) alter the structure and function of PDC-3. Our findings reveal that these substitutions modulate the dynamic flexibility of the Ω-loop and the R2-loop, reshaping the cavity of the active site. In particular, E219K and Y221A disrupt the tridentate hydrogen bond network around K67, thus lowering its <italic>pKa</italic> and promoting proton transfer to the catalytic residue S64. Markov state models reveal that E219K achieves enhanced catalysis by adopting stable, long-lived ‘active’ conformations, whereas Y221A facilitates activity by rapidly toggling between bond-formed and bond-broken states. In addition, substitutions influence key hydrogen bonds that control the opening and closure of the active-site pocket, consequently influencing the overall size. The pocket expands in all nine clinically identified variants, creating additional space to accommodate bulkier R1 and R2 cephalosporin side chains. Taken together, these results provide a mechanistic basis for how single residue substitutions in the Ω-loop affect catalytic activity. Insights into the structural dynamics of the catalytic site advance our understanding of emerging <italic>β</italic>-lactamase variants and can inform the rational design of novel inhibitors to combat drug-resistant <italic>P. aeruginosa</italic>.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Pseudomonas aeruginosa</italic></kwd><kwd>β-lactamase</kwd><kwd>molecular dynamics</kwd><kwd>adaptive bandit</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043z4tv69</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI063517</award-id><principal-award-recipient><name><surname>Bonomo</surname><given-names>Robert A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Clinically relevant Ω-loop mutations in PDC-3 reshape active-site dynamics to enhance β-lactamase activity, providing mechanistic insights that can guide the rational design of inhibitors.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Pseudomonas aeruginosa</italic> is a ubiquitous Gram-negative bacterium from the family Pseudomonadaceae (<xref ref-type="bibr" rid="bib42">Pang et al., 2019</xref>). This pathogen is commonly found in hospitals and other healthcare settings, where it can cause infections in people who are immunocompromised or have chronic conditions (<xref ref-type="bibr" rid="bib26">Kerr and Snelling, 2009</xref>). Pseudomonal infections are associated with high morbidity and mortality in many groups, including patients with cystic fibrosis, pneumonia, and chronic obstructive pulmonary disease (<xref ref-type="bibr" rid="bib15">Curran et al., 2018</xref>; <xref ref-type="bibr" rid="bib25">Jurado-Martín et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Malhotra et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Reynolds and Kollef, 2021</xref>). <inline-formula><alternatives><mml:math id="inf1"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft1">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-Lactam antibiotics, characterized by the presence of a <inline-formula><alternatives><mml:math id="inf2"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft2">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam ring in their chemical structure, are often the first-line treatment for bacterial infections as they tend to have fewer side effects and are less toxic than other antibiotics (<xref ref-type="bibr" rid="bib38">Mora-Ochomogo and Lohans, 2021</xref>). Mechanistically, <inline-formula><alternatives><mml:math id="inf3"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft3">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactams work by inhibiting the synthesis of the bacterial cell wall, which is necessary for the survival and growth of bacteria (<xref ref-type="bibr" rid="bib30">Lima et al., 2020</xref>). <inline-formula><alternatives><mml:math id="inf4"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft4">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam antibiotics are usually effective against a wide range of bacteria, but can lose their effectiveness if the bacteria develop resistance to them. <italic>P. aeruginosa</italic> is known for its ability to develop resistance to multiple classes of antimicrobial drugs (<xref ref-type="bibr" rid="bib22">Horcajada et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Pang et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Spagnolo et al., 2021</xref>). Therefore, the greatest challenges to eradicating <italic>P. aeruginosa</italic> infections are multidrug-resistant and extensively drug-resistant isolates. The World Health Organization has identified <italic>P. aeruginosa</italic> as a top-priority pathogen for research and development of new antibiotics due to its ability to cause serious infections and its increasing resistance to currently available treatment options (<xref ref-type="bibr" rid="bib60">Tacconelli et al., 2018</xref>).</p><p>The production of antibiotic-inactivating enzymes is one of the major mechanisms of intrinsic resistance in bacteria (<xref ref-type="bibr" rid="bib39">Munita and Arias, 2016</xref>). <italic>P. aeruginosa</italic> can express a class C <inline-formula><alternatives><mml:math id="inf5"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft5">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase, named <italic>Pseudomonas</italic>-derived cephalosporinase (PDC), which is an antibiotic-inactivating enzyme (<xref ref-type="bibr" rid="bib12">Colque et al., 2022</xref>). PDC-3 is a serine <inline-formula><alternatives><mml:math id="inf6"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft6">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase that can inactivate a broad range of <inline-formula><alternatives><mml:math id="inf7"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft7">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems, by breaking the amide bond of the <inline-formula><alternatives><mml:math id="inf8"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft8">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam ring through a catalytic serine (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>; <xref ref-type="bibr" rid="bib42">Pang et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Tripathi and Nair, 2013</xref>; <xref ref-type="bibr" rid="bib63">Tripathi and Nair, 2016</xref>). Cephalosporins are known to be highly susceptible to PDC-3 inactivation (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>). The active site of PDC-3 is located at the intersection of the enzyme’s α-helical and α/β domains (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The active site can be further divided into two distinct regions: the R1 site and the R2 site. These regions are defined by the specific binding interactions they facilitate with the R1 and R2 side chains of the cephalosporins, respectively (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The R1 site is surrounded by the <inline-formula><alternatives><mml:math id="inf9"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft9">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop, while the R2 site is encased by the R2-loop, which comprises the α helix H-10. The <inline-formula><alternatives><mml:math id="inf10"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft10">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and the R2-loop are located at opposite ends of the active site, with the catalytic serine residue positioned in the middle (<xref ref-type="bibr" rid="bib24">Jacoby, 2009</xref>). However, the <inline-formula><alternatives><mml:math id="inf11"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft11">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and R2-loop are particularly prone to amino acid substitutions, insertions, and deletions that expand the active site and accommodate larger R1 and R2 groups of the cephalosporins (<xref ref-type="bibr" rid="bib40">Nordmann and Mammeri, 2007</xref>). These modifications have been observed to enhance the capacity of the enzyme to hydrolyze a wider range of <inline-formula><alternatives><mml:math id="inf12"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft12">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam antibiotics (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>). The evolution of PDC-3 <inline-formula><alternatives><mml:math id="inf13"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft13">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase and its amino acid variants, which often result in enhanced catalytic activity and an expanded spectrum of cephalosporin hydrolysis, has garnered considerable interest in scientific research (<xref ref-type="bibr" rid="bib54">Ruedas-López et al., 2022</xref>). As previously reported, several PDC-3 <inline-formula><alternatives><mml:math id="inf14"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft14">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop variants, including V211A, V211G, G214A, G214R, E219A, E219G, E219K, Y221A, and Y221H were found in highly drug-resistant <italic>P. aeruginosa</italic> clinical isolates (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>). All residues in this study are annotated based on the structural alignment-based numbering of class C <inline-formula><alternatives><mml:math id="inf15"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft15">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase scheme (SANC) (<xref ref-type="bibr" rid="bib31">Mack et al., 2020</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Structures and catalytic mechanism of <inline-formula><alternatives><mml:math id="inf16"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft16">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam antibiotics and PDC-3 <inline-formula><alternatives><mml:math id="inf17"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft17">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase.</title><p>(<bold>A</bold>) Structures of representative <inline-formula><alternatives><mml:math id="inf18"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft18">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam antibiotics. The notation R (R1/R2) represents the point of addition of functional groups. (<bold>B</bold>) Structures of commonly used cephalosporins. The R1 side chains of the antibiotics are shown in red, while the R2 side chains are marked in blue. (<bold>C</bold>) General mechanism of PDC-3 <inline-formula><alternatives><mml:math id="inf19"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft19">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase hydrolysis of cephalosporins. (<bold>D</bold>) The overall structure of the protein is shown in a cartoon representation (PDB ID: 4HEF). The <inline-formula><alternatives><mml:math id="inf20"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft20">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and R2-loop are colored orange and red, respectively. The conserved residues in the active site are colored green and highlighted as sticks. The positions of all mutations (V211A/G, G214A/R, E219A/G/K, and Y221A/H) are highlighted as red spheres.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig1-v2.tif"/></fig><p>Molecular dynamics (MD) simulations provide valuable insights into the time-evolving dynamic behavior of biomolecules such as proteins (<xref ref-type="bibr" rid="bib21">Hollingsworth and Dror, 2018</xref>). Among various enhanced sampling methods, AdaptiveBandit molecular dynamics (AB-MD) stands out as a powerful, reinforcement learning (RL)-based adaptive sampling strategy (<xref ref-type="bibr" rid="bib44">Pérez et al., 2020</xref>). Compared to a single long equilibrium MD simulation (which can become trapped in a metastable state) or bias-based enhanced sampling techniques like accelerated MD (aMD) and Gaussian accelerated MD (GaMD) that add boost potentials to smooth the energy landscape and facilitate barrier crossing, AB-MD employs a reinforcement learning-inspired multi-armed bandit to adaptively guide multiple short, unbiased trajectories toward regions of underexplored conformational space (<xref ref-type="bibr" rid="bib4">Bhattarai and Miao, 2018</xref>). In a multi-armed bandit, each arm yields a reward, and an agent must balance exploration (trying less-sampled options) and exploitation (focusing on the best-known options). AB-MD applies this idea to MD by treating different regions of conformational space (or states) as the bandit arms. At each iteration, the algorithm decides from which state to launch a new MD simulation, aiming to maximize sampling efficiency while still obtaining an accurate, unbiased representation of the system’s equilibrium behavior.</p><p>In this study, the AB-MD approach was employed to explore the conformational landscape of PDC-3 and its variants at the atomistic level. Additionally, constant pH MD simulations were performed to examine the protonation-state behavior of key residues in the catalytic site. By analyzing the conformational ensembles and kinetics of PDC-3 through these simulations, we aimed to uncover underlying mechanisms governing the function of PDC-3 and its variants. Understanding the molecular mechanisms underlying PDC-3 function and the development of resistance is of paramount importance in combating <italic>P. aeruginosa</italic> infections. This knowledge can aid in the development of more effective treatments to combat these bacteria.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><sec id="s2-1"><title>Amino acid substitutions change the flexibility of <inline-formula><alternatives><mml:math id="inf21"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft21">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loops and R2-loops</title><p>To investigate how the mutations in the <inline-formula><alternatives><mml:math id="inf22"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft22">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 μs per system) were run. Both root-mean-square deviation (RMSD) and root-mean-square fluctuation (RMSF) analyses provide insights into the dynamic behavior and structural differences of biomolecules (<xref ref-type="bibr" rid="bib32">Maier et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Prabantu et al., 2022</xref>). Because AB-MD adaptively seeds new unbiased trajectories to expand conformational sampling, RMSD and RMSF are used here to summarize the structural variability and per-residue mobility observed across the collected trajectories. Firstly, the structural variability of the overall conformation of wild-type PDC-3 and its variants over the collected trajectories was investigated using pairwise RMSD analysis. The results of the RMSD analysis reveal that the wild-type PDC-3 displays a relatively low degree of structural variability, indicating that the protein maintains a relatively consistent overall conformation over the collected trajectories (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Similarly, the V211G, G214A, and Y221H variants also exhibit low RMSD values, which suggests that these structures are less flexible. In contrast, the V211A and E219G variants exhibit the highest RMSD values among the set of structures, indicating a high level of structural variability. This implies that these substitutions lead to increased conformational fluctuations over the collected trajectories. The G214R, E219A, E219K, and Y221A variants exhibit RMSD values that are intermediate between the wild-type and the most flexible variants, indicating that these amino acid substitutions have a moderate effect on the structural stability of the protein’s conformation, that is, not as significant as the V211A and E219G substitutions.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Structural stability and dynamic flexibility analyses of wild-type PDC-3 <inline-formula><alternatives><mml:math id="inf23"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft23">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase and its variants.</title><p>(<bold>A</bold>) Pairwise root mean square deviation (RMSD) comparison of wild-type PDC-3 and its variants. The cross-correlation matrix shows the RMSD values between each pair of structures. The color intensity represents the RMSD value, with lower values indicating a higher degree of structural similarity between the structures. (<bold>B</bold>) The root-mean-square fluctuation (RMSF) of wild-type PDC-3 and its variants. The <inline-formula><alternatives><mml:math id="inf24"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft24">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop (residues G183 to S226) is highlighted in yellow, and the R2-loop (residues L280 to Q310) is highlighted in blue. (<bold>C</bold>) Core C<sub>α</sub> RMSD superimposition of wild-type PDC-3 and its mutants. The blue parts represent the least mobile Cα atoms (80%) while the red parts highlight the most mobile atoms (20%).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The distribution of RMSD values of wild-type PDC-3 and its variants.</title><p>The three violin plots illustrate the RMSD values of the complete protein, the <inline-formula><alternatives><mml:math id="inf25"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft25">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop, and the R2-loop, respectively. The width of each violin plot represents the density of data points at a given RMSD value. The median and quartiles are indicated by the white dot and the thick black line inside the violin plot, respectively. The crystal structure PDB ID 4HEF is used as the reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>RMSD as a function of the fraction of the atoms considered in the alignment.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig2-figsupp2-v2.tif"/></fig></fig-group><p>To identify regions that contribute the most to the conformational changes in the wild-type PDC-3 and its variants, the RMSF values of Cα atoms were calculated. High RMSF values indicate a high degree of flexibility or mobility for the corresponding atoms, while low RMSF values indicate a significant degree of rigidity (<xref ref-type="bibr" rid="bib5">Bornot et al., 2011</xref>). The wild-type PDC-3 and the G214A, G214R, E219G, and Y221A variants exhibit high flexibility in their <inline-formula><alternatives><mml:math id="inf26"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft26">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop, as evidenced by the relatively large per-residue RMSF values observed (approximately 4 Å). In contrast, the V211A, V211G, E219K, and Y221H variants display more constrained conformations in the <inline-formula><alternatives><mml:math id="inf27"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft27">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop. Notably, the V211A and V211G variants demonstrate the highest stability in the <inline-formula><alternatives><mml:math id="inf28"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft28">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop, with average RMSF values around 1.5 Å, whereas the E219K and Y221H variants exhibit intermediate flexibility, with RMSF values averaging between 2 and 2.5 Å. In terms of the R2-loop, wild-type PDC-3 displays a relatively low degree of flexibility while all variants exhibit an increase in structural flexibility. This suggests that these substitutions have a significant impact on the stability of the R2-loop, potentially affecting enzyme function. A detailed observation of the individual variants reveals that the V211A variant exhibits a particularly high degree of flexibility, as evidenced by the comparatively higher RMSF values, followed by the E219G variant. On the other hand, the Y221A and Y221H variants exhibit a relatively lower degree of flexibility, as inferred by the lower RMSF values observed (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Therefore, the flexibility of PDC-3 is predominantly localized to the <inline-formula><alternatives><mml:math id="inf29"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft29">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>- and R2-loops, whereas the remainder of the structure is comparatively rigid.</p><p>The importance of <inline-formula><alternatives><mml:math id="inf30"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft30">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and R2-loop in class C <inline-formula><alternatives><mml:math id="inf31"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft31">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamases has been previously confirmed (<xref ref-type="bibr" rid="bib47">Philippon et al., 2022</xref>). These loops play a crucial role in the binding and activity of the class C <inline-formula><alternatives><mml:math id="inf32"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft32">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamases (<xref ref-type="bibr" rid="bib47">Philippon et al., 2022</xref>). Specifically, residues V211 and Y221 within the <inline-formula><alternatives><mml:math id="inf33"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft33">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop have been identified to engage in hydrophobic interactions with the R1 side chains of cephalosporins. The substitution of V211A has been reported to be associated with acquired resistance to cefepime or cefpirome (<xref ref-type="bibr" rid="bib52">Rodríguez-Martínez et al., 2010</xref>). Additionally, the characteristic aminothiazole ring found in most third-generation cephalosporins interacts with Y221 in an edge-to-face manner, which represents typical quadrupole-quadrupole interactions. However, Y221 can sometimes create steric clashes that prevent ligands from entering the binding sites (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Powers and Shoichet, 2002</xref>). Deletion of Y221 has been observed to broaden substrate specificity and confer resistance to ceftazidime-avibactam (<xref ref-type="bibr" rid="bib29">Lahiri et al., 2015</xref>). Moreover, the expanded <inline-formula><alternatives><mml:math id="inf34"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft34">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop of P99, another member of class C <inline-formula><alternatives><mml:math id="inf35"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft35">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamases, exhibits conformational flexibility that may facilitate the hydrolysis of oxyimino <inline-formula><alternatives><mml:math id="inf36"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft36">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactams by making the acyl intermediate more accessible to attack by water (<xref ref-type="bibr" rid="bib13">Crichlow et al., 1999</xref>). In terms of the R2-loop, it has been observed that the N289 (N287 in PDC-3) forms hydrogen-bonding interactions with the C4 carboxylate directly in the AmpC/13 (moxalactam) complex (<xref ref-type="bibr" rid="bib14">Crichlow et al., 2001</xref>). Furthermore, the T289, A292, and L293 residues within the R2-loop of class C <inline-formula><alternatives><mml:math id="inf37"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft37">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamases have been found to exhibit hydrophobic contacts with the dimethyl group in the R2 chains of cephalosporins (<xref ref-type="bibr" rid="bib49">Powers and Shoichet, 2002</xref>). Additional research suggests that the removal of the R2 group in cephalosporins occurs, while the R1 group remains intact (<xref ref-type="bibr" rid="bib10">Chaudhry et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Perez-Inestrosa et al., 2005</xref>). This observation indicates that the high flexibility of the R2-loop could be a crucial factor in stabilizing substrates during both the acylation and deacylation steps simultaneously. Overall, the flexibility or mobility of the <inline-formula><alternatives><mml:math id="inf38"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft38">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loops and R2-loops allows the PDC-3 active site cavity to adopt different sizes and shapes, thus affecting the binding of different <inline-formula><alternatives><mml:math id="inf39"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft39">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactams and allowing for extended-spectrum activity of some class C <inline-formula><alternatives><mml:math id="inf40"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft40">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamases.</p></sec><sec id="s2-2"><title>E219K and Y221A mutations facilitate proton transfer</title><p>The utilization of Markov state models (MSMs) enabled the analysis of long-term conformational alterations of wild-type PDC-3 and its variants by filtering out local fluctuations related to thermal motion and focusing on underlying conformational transformations (<xref ref-type="bibr" rid="bib6">Bowman et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">Husic and Pande, 2018</xref>; <xref ref-type="bibr" rid="bib55">Scherer et al., 2015</xref>; <xref ref-type="bibr" rid="bib61">Trendelkamp-Schroer and Noé, 2013</xref>). Previous analyses demonstrated that, in addition to the catalytic site, the most significant structural changes occur in the <inline-formula><alternatives><mml:math id="inf41"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft41">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>- and R2-loops. Consequently, hydrogen bonds and salt bridges in those loops and in the catalytic site were identified for MSM construction. Distances for all relevant interactions were computed in (i) the active motifs (S<sup>64</sup>XXK<sup>67</sup>, Y<sup>150</sup>SN<sup>152</sup>, K<sup>315</sup>TG<sup>317</sup>), (ii) the <inline-formula><alternatives><mml:math id="inf42"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft42">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop (residues G183–S226), and (iii) the R2-loop (residues L280–Q310). To establish the correlation between structural dynamics and active-site pocket, correlation coefficients were computed between the distances of these interactions and the volume of the active-site pockets. A correlation coefficient exceeding 0.3 or falling below –0.3 indicates a positive or negative relationship, respectively. Only the distances of salt bridges and hydrogen bonds that exhibited a positive or negative relationship with the volume of the active-site pockets were selected as features to construct the MSMs. This resulted in the selection of 8 salt bridges and 24 hydrogen bonds (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Free energy landscapes and metastable-state distributions from Markov state models reveal key conformational transitions in wild-type PDC-3 and its variants.</title><p>(<bold>A</bold>) The free energy landscape for the microstates of the wild-type PDC-3 and its mutants. (<bold>B</bold>) The metastable states grouped from microstates of PDC-3 and its variants systems. The microstates were grouped by the PCCA method into metastable states in all systems.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>The mean first passage time (MFPT) estimates.</title></caption><media mimetype="application" mime-subtype="docx" xlink:href="elife-107688-fig3-data1-v2.docx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Correlation coefficients between the distances of key interactions (32 features) and volume of active-site pockets.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>The convergence behavior of the implied timescales related to the first 10 slowest processes.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>The Chapman–Kolmogorov test plot of wild-type PDC-3.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>The Chapman–Kolmogorov test plot of V211A variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>The Chapman–Kolmogorov test plot of V211G variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp5-v2.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 6.</label><caption><title>The Chapman–Kolmogorov test plot of G214A variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp6-v2.tif"/></fig><fig id="fig3s7" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 7.</label><caption><title>The Chapman–Kolmogorov test plot of G214R variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp7-v2.tif"/></fig><fig id="fig3s8" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 8.</label><caption><title>The Chapman–Kolmogorov test plot of E219A variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp8-v2.tif"/></fig><fig id="fig3s9" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 9.</label><caption><title>The Chapman–Kolmogorov test plot of E219G variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp9-v2.tif"/></fig><fig id="fig3s10" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 10.</label><caption><title>The Chapman–Kolmogorov test plot of E219K variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp10-v2.tif"/></fig><fig id="fig3s11" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 11.</label><caption><title>The Chapman–Kolmogorov test plot of Y221A variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp11-v2.tif"/></fig><fig id="fig3s12" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 12.</label><caption><title>The Chapman–Kolmogorov test plot of Y221H variant.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig3-figsupp12-v2.tif"/></fig></fig-group><p>Inspection of the MSM stationary distributions reveals that E219K and Y221A prominently occupy metastable conformations in which the K67-centered tridentate hydrogen-bond network is fully disrupted, with K67(NZ)–S64(OG), K67(NZ)–N152(OD1), and K67(NZ)–G220(O) all broken (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref>–<xref ref-type="fig" rid="fig4s3">3</xref>). Notably, this ‘fully broken’ configuration appears only in E219K and Y221A variants (states 1, 6, and 7 in E219K, and state 3 in Y221A). These three hydrogen bonds could potentially have implications for the catalytic activity of the enzyme, as S64 is a catalytic residue involved in the acylation step of the <inline-formula><alternatives><mml:math id="inf43"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft43">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase. K67 is believed to act as a general base in the acylation step of the <inline-formula><alternatives><mml:math id="inf44"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft44">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase catalytic mechanism, abstracting a proton from the hydroxyl group of S64, which in turn facilitates the nucleophilic attack of the <inline-formula><alternatives><mml:math id="inf45"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft45">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam ring (<xref ref-type="bibr" rid="bib62">Tripathi and Nair, 2013</xref>; <xref ref-type="bibr" rid="bib63">Tripathi and Nair, 2016</xref>). Therefore, K67 is thought to toggle between protonated and deprotonated states to facilitate proton transfer in the catalytic cycle (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). However, when K67 is involved in persistent and energetically favored hydrogen bonding interactions with S64, N152, and G220, these stable interactions can lock it in the protonated state. By contrast, the fully disrupted tridentate network adopted in E219K and Y221A should alleviate this conformational constraint, enabling K67 to more readily undergo the protonation state toggling required for catalysis.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>E219K and Y221A mutations reshape the catalytic conformations and protonation states of K67.</title><p>(<bold>A</bold>) Hydrogen bond interactions (dashed lines) between K67(NZ)-S64(OG), K67(NZ)-N152(OD1), and K67(NZ)-G220(O) are formed in wild-type PDC-3 (orange) but broken in the E219K (pink) and Y221A (blue) variants. (<bold>B</bold>) The pH titration curves for K67 based on three replicate constant pH MD simulations. Each point indicates the fraction of deprotonated K67 at a given pH, and the lines are best fits to a titration model. The estimated <inline-formula><alternatives><mml:math id="inf46"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft46">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> values are shown in the legend.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the color indicating the K67(NZ)-S64(OG) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the color indicating the K67(NZ)-N152(OD1) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the color indicating the K67(NZ)-G220(O) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Time-resolved deprotonation of K67 in WT, E219K, and Y221A over 200-ns constant-pH MD simulations at six pH values (5, 6, 7, 8, 9, 10, and 11).</title><p>Each panel plots the deprotonated fraction of K67 versus simulation time for one replica.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig4-figsupp4-v2.tif"/></fig></fig-group><p>The protonation state (<inline-formula><alternatives><mml:math id="inf47"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft47">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula>) of K67 in the enzyme is therefore critical: a lowered <inline-formula><alternatives><mml:math id="inf48"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft48">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> could allow K67 to exist as a neutral general base at physiological pH, ready to accept a proton in catalysis (<xref ref-type="bibr" rid="bib11">Chen et al., 2009</xref>). Indeed, analogies from related enzymes suggest that catalytic lysines often have depressed <inline-formula><alternatives><mml:math id="inf49"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft49">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> values (e.g., K47 in PBP5 and K73 in TEM-1) to enable catalytic function (<xref ref-type="bibr" rid="bib18">Golemi-Kotra et al., 2004</xref>; <xref ref-type="bibr" rid="bib64">Zhang et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Shi et al., 2008</xref>; <xref ref-type="bibr" rid="bib36">Meroueh et al., 2005</xref>). However, directly measuring or computing the <inline-formula><alternatives><mml:math id="inf50"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft50">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> of a buried lysine in a large enzyme is challenging. Constant pH molecular dynamics simulations (CpHMD) provide a powerful <italic>in silico</italic> approach to estimate <inline-formula><alternatives><mml:math id="inf51"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft51">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> by allowing protonation states to fluctuate according to a chosen pH (<xref ref-type="bibr" rid="bib27">Kim et al., 2015</xref>). Here, we employed CpHMD to compute the <inline-formula><alternatives><mml:math id="inf52"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft52">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> of K67 in wild-type PDC-3 and compare it with the E219K and Y221A variants. Titration curves generated from pH-replicated simulations were analyzed to extract K67 <inline-formula><alternatives><mml:math id="inf53"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft53">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> values. Our results indicate that, in wild-type PDC-3, K67 exhibits a <inline-formula><alternatives><mml:math id="inf54"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft54">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> in the range of approximately 8.50–8.79 (<xref ref-type="fig" rid="fig4">Figure 4</xref>). By contrast, the E219K mutation dramatically reduces the <inline-formula><alternatives><mml:math id="inf55"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft55">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> of K67 to approximately 6.32–6.71, causing K67 to be predominantly deprotonated (neutral) at physiological pH. This deprotonated form is conducive to K67 functioning as a general base readily accepting a proton and thereby facilitating the nucleophilic attack of the S64 hydroxyl group on the <inline-formula><alternatives><mml:math id="inf56"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft56">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam ring (<xref ref-type="bibr" rid="bib62">Tripathi and Nair, 2013</xref>; <xref ref-type="bibr" rid="bib63">Tripathi and Nair, 2016</xref>). The Y221A mutation also shifts <inline-formula><alternatives><mml:math id="inf57"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft57">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> of K67 down (7.60–8.06), though to a lesser degree than E219K. As previously noted, the E219K and Y221A mutations weaken the tridentate hydrogen-bond networks (K67(NZ)-S64(OG), K67(NZ)-N152(OD1), K67(NZ)-G220(O)), thereby enabling K67 to more flexibly adjust both its conformation and its protonation state, which in turn promotes more efficient proton transfer. Experimentally, these mutations also confer increased sensitivity to cephalosporin antibiotics, which aligns with the conformational and protonation-state shifts observed in the simulations (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>). Collectively, these findings reveal that the E219K and Y221A substitutions disrupt the tridentate hydrogen-bond network, which lowers the <inline-formula><alternatives><mml:math id="inf58"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft58">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> of K67 and enhances its ability to act as a general base. This elevated proton-transfer efficiency, in turn, improves the enzyme’s catalytic performance.</p><p>Moreover, the mean first passage time (MFPT) data indicate that once the E219K variant forms one of these bond-broken states, it remains there for thousands of nanoseconds (8,262.0±2,573.0 ns to 12,769.0±3327.0 ns) before transitioning to a bond-formed state (state 3) (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Likewise, the reverse process also occurs on a microsecond timescale, demonstrating that both directions are kinetically stabilized in E219K. As a result, E219K displays two dominant energy minima in its free-energy landscape, whereas other variants typically show only one (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Prolonged residence in a bond-broken conformation implies that K67 is more likely to remain deprotonated, enhancing catalytic function. By contrast, in Y221A, the equivalent bond-broken state (state 3) shifts more readily into other metastable states, including the most stable state 7 (bond-formed), in only 780.2±46.8 ns. Although the reverse transition from bond-formed to bond-broken in Y221A requires a somewhat longer 1,737.6±139.7 ns, this timescale remains far shorter than E219K’s multi-microsecond range. Consequently, Y221A can dynamically switch between ‘formed’ and ‘broken’ conformations with much greater ease. This difference in conformational kinetics helps explain differences in how each mutant enhances hydrolysis rates. E219K achieves it through stable, long-lived ‘active’ conformations, while Y221A relies on faster switching and conformational plasticity.</p></sec><sec id="s2-3"><title>Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of <inline-formula><alternatives><mml:math id="inf59"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft59">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactams</title><p>In addition to facilitating catalytic proton transfer, <inline-formula><alternatives><mml:math id="inf60"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft60">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop substitutions also remodel the steric architecture of the active site. Specifically, the K67–G220 hydrogen bond discussed above may directly influence the shape and volume of the R1 side of the binding cavity. K67 is part of the conserved catalytic motif S<sup>64</sup>XXK<sup>67</sup>, whereas G220 resides within the <inline-formula><alternatives><mml:math id="inf61"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft61">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Likewise, A292 and N287 are located on the R2-loop, while Y150 and N314 are also located in the catalytic motifs. The Y150(N)–A292(O) and N287(ND2)–N314(OD1) interactions are therefore proposed to regulate the space available on the R2 side of the pocket. Importantly, the MSM-derived metastable states separate into basins in which these contacts remain formed and basins in which they are broken (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref> and <xref ref-type="fig" rid="fig5s2">2</xref>). Because transitions between metastable states occur on slow timescales, this contact switching likely reflects slow loop rearrangements that control the active-site cavity (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Structural visualization of the enlarged active-site pocket.</title><p>(<bold>A</bold>) The K67(NZ)-G220(O), Y150(N)-A292(O), and N287(ND2)-N314(OD1) interactions in representative structures of wild-type PDC-3, Y221A, and V211A variants. The yellow dashed lines represent the interactions. (<bold>B</bold>) The active-site pockets of wild-type PDC-3, Y221A, and V211A variants are shown as surface representation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the color indicating the Y150(N)-A292(O) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the color indicating the N287(ND2)-N314(OD1) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig5-figsupp2-v2.tif"/></fig></fig-group><p>To validate this hypothesis, the mean pocket volume and the donor–acceptor distances for the three putative hydrogen-bond pairs were computed for each metastable state (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In wild-type PDC-3, the pocket remains compact across the metastable ensemble. The global free-energy minimum basin of the wild-type landscape (state 7) exhibits a mean volume of 1048.9 ± 143.7 Å<sup>3</sup> (<xref ref-type="fig" rid="fig3">Figures 3A and</xref> <xref ref-type="fig" rid="fig6">6A</xref>). In this state, the three interactions are predominantly consistent with hydrogen-bonding geometry, as reflected by their mean donor–acceptor distances for K67(NZ)–G220(O) (3.2 Å), Y150(N)–A292(O) (3.2 Å), and N287(ND2)–N314(OD1) (3.7 Å) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). In contrast, Y221A shows pronounced pocket expansion in multiple states. State 3 reaches 1766.8 ± 274.9 Å<sup>3</sup> (+68.4% relative to the wild-type global-minimum state, state 7), and state 5 reaches 1654.9 ± 275.8 Å<sup>3</sup> (+57.8% relative to the same reference). In both states, the three hydrogen-bond pairs are largely disrupted, with the corresponding donor–acceptor distances substantially increased. This mechanistic mapping provides a direct structural rationale for how single <inline-formula><alternatives><mml:math id="inf62"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft62">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop substitutions can expand the active-site cavity to accommodate bulkier R1 and R2 groups of <inline-formula><alternatives><mml:math id="inf63"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft63">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactams (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Y221A state 1 is also associated with a large pocket volume of 1399.9 ± 272.4 Å<sup>3</sup>. Although the R2-side pairs N287(ND2)–N314(OD1) and Y150(N)–A292(O) remain consistent with hydrogen-bonding geometry (3.1 Å and 3.6 Å, respectively), the K67(NZ)–G220(O) distance increases to 11.2 Å. Pronounced pocket expansion is also observed in E219G. In E219G state 5, the pocket reaches 1546.1 ± 233.1 Å<sup>3</sup> (+47.4% relative to the wild-type global-minimum state, state 7), with all three hydrogen-bond pairs largely disrupted. Although these expansive states are not the global energy minimum in Y221A or E219G (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), they align with well-defined low free-energy basins, indicating that substantial cavity expansion can be thermodynamically accessible.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Metastable-state pocket volumes and key interaction patterns across wild-type PDC-3 and its variants.</title><p>(<bold>A</bold>) Mean active-site pocket volume for each metastable state in wild-type PDC-3 and its variants. Bars denote the mean pocket volume (Å<sup>3</sup>), and error bars indicate the standard deviation across frames assigned to each state. (<bold>B</bold>) Heat maps show the mean distances (Å) for three contacts that may contribute to pocket-volume changes across MSM metastable states (K67(NZ)–G220(O), Y150(N)–A292(O), and N287(ND2)–N314(OD1)). Color encodes the distance magnitude, with blue indicating lower values and red indicating higher values.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Mean distances of three contacts (K67(NZ)–G220(O), Y150(N)–A292(O), and N287(ND2)–N314(OD1)) across metastable states in wild-type PDC-3 and its variants.</title><p>Bars denote the mean donor–acceptor distance (Å) for each contact within each state, and error bars indicate the standard deviation across frames assigned to that state.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-fig6-figsupp1-v2.tif"/></fig></fig-group><p>A more striking thermodynamic shift is observed for E219K. In this variant, the most expanded-pocket ensemble coincides with a dominant free-energy minimum. State 7 exhibits a large pocket volume of 1477.4 ± 261.3 Å<sup>3</sup>, corresponding to a 40.9% increase relative to the wild-type global-minimum state. Structurally, this minimum is characterized by a pronounced expansion on the R1 side, with the mean K67(NZ)–G220(O) distance extended to 9.5 Å. In addition, the R2-side hydrogen bonds Y150(N)–A292(O) and N287(ND2)–N314(OD1) are disrupted, with mean donor–acceptor distances of 4.5 Å and 4.5 Å, respectively. This thermodynamic stabilization of an expanded-pocket minimum provides a plausible mechanistic basis for the pronounced resistance phenotype, in which the E219K mutant shows markedly reduced susceptibility to cephalosporins (<xref ref-type="bibr" rid="bib3">Barnes et al., 2018</xref>).</p><p>G214R state 4 and V211G state 3 also sample enlarged active-site cavities. In these states, the expansions arise primarily from outward displacements of the R2-loop, reflected by markedly increased mean N287(ND2)–N314(OD1) and Y150(N)–A292(O) distances, while the R1-side architecture remains comparatively compact. Notably, these expansive conformations occupy sparsely populated, higher-free-energy basins, indicating that they are not strongly stabilized in the apo ensemble. Instead, they likely represent excited-state expansions that are only transiently accessed but can be selectively stabilized upon substrate binding. Thus, ligands with bulky substituents might capture these pre-existing R2-expanded conformations, shifting the ensemble toward a larger cavity and thereby enabling accommodation of larger R2 groups.</p></sec><sec id="s2-4"><title>Conclusions</title><p>This investigation of the effects of substitutions in the PDC-3 <inline-formula><alternatives><mml:math id="inf64"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft64">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase has provided valuable information on the protein’s dynamics. The study indicates that substitutions can have a significant impact on the stability and flexibility of the <inline-formula><alternatives><mml:math id="inf65"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft65">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and R2-loop, both of which are critical for the <inline-formula><alternatives><mml:math id="inf66"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft66">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase function. Specifically, the G214A, G214R, E219G, and Y221A variants, as well as the wild-type PDC-3, exhibit high flexibility in the <inline-formula><alternatives><mml:math id="inf67"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft67">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop, while the V211A and E219G variants show the highest flexibility in the R2-loop. Moreover, the hydrogen-bond network around K67—specifically K67(NZ)–S64(OG), K67(NZ)–N152(OD1), and K67(NZ)–G220(O)—governs the proton-transfer step essential for <inline-formula><alternatives><mml:math id="inf68"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft68">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactam hydrolysis. When these three bonds remain intact, K67 tends to stay protonated, limiting its availability to accept a proton from S64. Mutations such as E219K and Y221A disrupt this tridentate network, reducing K67’s <inline-formula><alternatives><mml:math id="inf69"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft69">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> and facilitating efficient proton transfer in hydrolysis. Additionally, K67(NZ)–G220(O), Y150(N)–A292(O), and N287(ND2)–N314(OD1) interactions further modulate R1/R2-loop conformations. Breaking these hydrogen bonds typically shifts the active site to a more expansive configuration, accommodating larger cephalosporin substrates. Overall, the findings of this study provide significant insight into the dynamics of the PDC-3 <inline-formula><alternatives><mml:math id="inf70"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft70">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula>-lactamase, revealing the critical roles played by the <inline-formula><alternatives><mml:math id="inf71"><mml:mi mathvariant="normal">Ω</mml:mi></mml:math><tex-math id="inft71">\begin{document}$\Omega$\end{document}</tex-math></alternatives></inline-formula>-loop and R2-loop in its function. These insights gained from this study will aid in the design of more potent antibiotics and <inline-formula><alternatives><mml:math id="inf72"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft72">\begin{document}$\beta $\end{document}</tex-math></alternatives></inline-formula> inhibitors for treating bacterial infections.</p></sec></sec><sec id="s3" sec-type="methods"><title>Methods</title><sec id="s3-1"><title>Initial structure preparation</title><p>All-atom MD simulations of wild-type PDC-3 and its variants were performed. First, the simulations of their conformations were initiated from the X-ray crystallographic structure (PDB ID: 4HEF) at 1.86 Å, after modification of T79A (<xref ref-type="bibr" rid="bib28">Lahiri et al., 2013</xref>). PDC-3 wild-type and nine variants (V211A, V211G, G214A, G214R, E219A, E219G, E219K, Y221A, and Y221H) were constructed <italic>in silico</italic> using the ICM mutagenesis program (<xref ref-type="bibr" rid="bib1">Abagyan et al., 1994</xref>). To ensure the accurate protonation states of the protein, PROPKA 3.0 was employed to assign the protonation states of N-terminus, C-terminus, cationic residues, and anionic residues based on a neutral pH local environment (<xref ref-type="bibr" rid="bib41">Olsson et al., 2011</xref>). In addition, all acidic residues were negatively charged, while alkaline Lys and Arg residues remained positively charged. His was protonated based upon the suggestion by PROPKA 3.0 analysis and also checked by visual inspection.</p></sec><sec id="s3-2"><title>AdaptiveBandit simulations</title><p>AdaptiveBandit MD (AB-MD) simulation is a reinforcement learning-based enhanced sampling method that offers a more efficient exploration of the protein’s conformational space while maintaining unbiased, thermodynamically accurate ensembles (<xref ref-type="bibr" rid="bib44">Pérez et al., 2020</xref>). The advantage of using AB-MD is that it does not alter the underlying potential energy surface, it retains physically realistic dynamics and eliminates the need for reweighting of biased trajectories. As a result, AB-MD can attain a similar or greater depth of conformational sampling with significantly less total simulation time (i.e. lower computational cost) than either extended conventional MD or other enhanced sampling approaches.</p><p>The WT and variant structures served as the starting point for subsequent molecular dynamics (MD) simulation. Multi-microsecond MD simulations of wild-type PDC-3 and its variants were conducted using the Amberff14SB force field (<xref ref-type="bibr" rid="bib32">Maier et al., 2015</xref>). All simulations were run using the ACEMD engine (<xref ref-type="bibr" rid="bib16">Doerr et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Harvey et al., 2009</xref>). Each structure was solvated in a pre-equilibrated periodic cubic box of water molecules represented by the three-point charge TIP3P model, whose boundary is at least 10 Å from any atoms so that the protein does not interact with its periodic images. Periodic boundary conditions in all directions were utilized to reduce finite system size effects. The potassium ions were added to make each system electrically neutral. Long-range electrostatic interactions were computed using the particle mesh Ewald summation method (<xref ref-type="bibr" rid="bib9">Cerutti et al., 2009</xref>). Subsequently, each system was energy minimized for 5000 steps by conjugate gradient to remove any local atomic clashes and then equilibrated for 5 ns at 1 atmospheric pressure using Berendsen barostat (<xref ref-type="bibr" rid="bib17">Feenstra et al., 1999</xref>).</p><p>Initial velocities within each simulation were sampled from the Maxwell–Boltzmann distribution at a temperature of 300 K. Simulations were performed in the NVT ensemble using a Langevin thermostat with a damping of 0.1 ps-1 and hydrogen mass repartitioning scheme to achieve time steps of 4 fs. Multiple short MSM-based adaptively sampled simulations were run using the ACEMD molecular dynamics engine (<xref ref-type="bibr" rid="bib16">Doerr et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Harvey et al., 2009</xref>). The standard adaptive sampling algorithm performs several rounds of short parallel simulations. To avoid any redundant sampling, the algorithm generates a Markov state model (MSM) and uses the stationary distribution of each state to obtain an estimate of its free energy. It then selects any sampled conformation from a low free energy stable state and respawns a new round of simulations. In this context, the MetricSelfDistance function was set to consider the number of native Cα contacts formed for all residues, which were then used to build the MSMs. The exploration value was 0.01 and goal-scoring function was set to 0.3. For each round, 4 simulations of 300 ns were run in parallel until the cumulative time exceeded 30 μs. The trajectory frames were saved every 0.1 ns. 100 trajectories for each system were collected with each trajectory counting 3000 frames.</p></sec><sec id="s3-3"><title>Constant pH molecular dynamics</title><p>To investigate the protonation behavior of K67 in wild-type PDC-3 and its E219K and Y221A variants, K67, Y150, E/K219, and K315 were selected as titratable sites in CpHMD simulations because they lie in proximity to the site of interest (K67) and together form its immediate electrostatic network (<xref ref-type="bibr" rid="bib27">Kim et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Lahiri et al., 2013</xref>). The starting structures were identical to those used for AB-MD. The simulations were performed in the Amber suite with the ff99SB force field and an implicit Generalized Born (GB) solvent model (<xref ref-type="bibr" rid="bib32">Maier et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Mongan et al., 2004</xref>). The protein–solvent complex was energy-minimized for a total of 5000 steps—10 steps of steepest-descent followed by 4990 steps of conjugate-gradient—with harmonic positional restraints (10 kcal/mol·Å<sup>2</sup>) on the backbone atoms to relax side-chain clashes (<xref ref-type="bibr" rid="bib7">Brooks et al., 1983</xref>; <xref ref-type="bibr" rid="bib56">Schlegel, 1982</xref>). The system was then heated from 10 K to 300 K over 1 ns, followed by another 1 ns of equilibration at 300 K under Langevin dynamics Schneider and Stoll (1978), with a 2 fs time step and SHAKE constraints on hydrogen-containing bonds. During heating, a weaker restraint (2 kcal/mol·Å<sup>2</sup>) was applied to the backbone atoms to maintain the overall fold while allowing side-chain relaxation, and protonation states were kept fixed in this phase. Equilibrium simulations under constant pH conditions were subsequently conducted at pH 5, 6, 7, 8, 9, 10, and 11 by periodically (every 10 steps) attempting protonation-state changes via a Monte Carlo protocol (<xref ref-type="bibr" rid="bib27">Kim et al., 2015</xref>). Each pH condition consisted of 50 ns of equilibration followed by 200 ns of production. To confirm convergence, the deprotonation fraction of each residue was monitored over time and found to reach a stable plateau within the final portion of the production simulations. Consequently, the last 50 ns of production for each pH value were used to calculate the deprotonation fractions, ensuring that the analyzed region reflected a converged state. Each system was simulated in triplicate, ultimately providing consistent K67 <inline-formula><alternatives><mml:math id="inf73"><mml:mi>p</mml:mi><mml:msub><mml:mi>K</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft73">\begin{document}$pK_{a}$\end{document}</tex-math></alternatives></inline-formula> estimates for the wild-type, E219K, and Y221A variants. All analyses were done with AmberTools <italic>cphstats</italic> and in-house Python scripts (<xref ref-type="bibr" rid="bib8">Case et al., 2023</xref>).</p></sec><sec id="s3-4"><title>Markov state models</title><p>The PyEMMA software (version 2.5.9) was employed to construct the Markov state models (<xref ref-type="bibr" rid="bib23">Husic and Pande, 2018</xref>; <xref ref-type="bibr" rid="bib55">Scherer et al., 2015</xref>). The software determines the kinetically relevant metastable states and their interconversion rate from all trajectories of the all-atom molecular dynamics of the wild-type PDC-3 and its variants. Firstly, to evaluate the MSM construction, the conformations defining each frame of the MD trajectories were converted into an intuitive basis. In this step, the features that can represent the slow dynamical modes of these systems were selected. Then, the conformational space was projected to a two-dimensional space using time-lagged independent component analysis (TICA) (<xref ref-type="bibr" rid="bib45">Pérez-Hernández and Noé, 2016</xref>). Using the <italic>k</italic>-means clustering technique, all conformations from MD simulations were grouped into microstates based on the TICA embedding (<xref ref-type="bibr" rid="bib43">Peng et al., 2018</xref>). The conformations in the same cluster are geometrically similar and interconvert quickly. After that, the transition matrix between the microstates was built using Bayesian estimation at the appropriate lag time (<xref ref-type="bibr" rid="bib61">Trendelkamp-Schroer and Noé, 2013</xref>). The lag time was selected where the implied time scales converged, and the transitions between the microstates became the Markovian process. Each indicated time scale represents the average transition time between two groups of states. The microstates were then clustered into a few metastable states using Perron cluster cluster analysis (PCCA) based on their kinetic similarities (<xref ref-type="bibr" rid="bib6">Bowman et al., 2009</xref>). Additionally, the Chapman–Kolmogorov (CK) test was performed to validate the constructed model further (<xref ref-type="bibr" rid="bib2">Barendregt et al., 2019</xref>). The CK test measures the reliability of the Markov state models by comparing the predicted residence probability of each microstate obtained from MSMs with those directly computed from MD simulations at longer timescales. Furthermore, the free energies for each metastable state (<inline-formula><alternatives><mml:math id="inf74"><mml:msub><mml:mi>S</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft74">\begin{document}$S_{i}$\end{document}</tex-math></alternatives></inline-formula>) were computed from its stationary MSM probability <inline-formula><alternatives><mml:math id="inf75"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>π</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft75">\begin{document}$\pi $\end{document}</tex-math></alternatives></inline-formula> using the relation:<disp-formula id="equ1"><label>(1)</label><alternatives><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>G</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>B</mml:mi></mml:mrow></mml:msub><mml:mi>T</mml:mi><mml:mi>ln</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:msub><mml:mi>π</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:math><tex-math id="t1">\begin{document}$$\displaystyle  \Delta G(S_{i}) = -k_{B}T\ln(\sum_{j \in S_{i}}\pi_{j})$$\end{document}</tex-math></alternatives></disp-formula></p><p>where <inline-formula><alternatives><mml:math id="inf76"><mml:msub><mml:mi>π</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft76">\begin{document}$\pi_{j}$\end{document}</tex-math></alternatives></inline-formula> denotes the MSM stationary weight of the <italic>j</italic>th microstate, <inline-formula><alternatives><mml:math id="inf77"><mml:msub><mml:mi>k</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft77">\begin{document}$k_{B}$\end{document}</tex-math></alternatives></inline-formula> is the Boltzmann constant, and <inline-formula><alternatives><mml:math id="inf78"><mml:mi>T</mml:mi></mml:math><tex-math id="inft78">\begin{document}$T$\end{document}</tex-math></alternatives></inline-formula> is the temperature. Subsequently, the MFPT out of and into the macrostate <inline-formula><alternatives><mml:math id="inf79"><mml:msub><mml:mi>S</mml:mi><mml:mrow class="MJX-TeXAtom-ORD"><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft79">\begin{document}$S_{i}$\end{document}</tex-math></alternatives></inline-formula> were computed using the Bayesian MSM (<xref ref-type="bibr" rid="bib48">Polizzi et al., 2016</xref>).</p></sec><sec id="s3-5"><title>Structural analysis</title><p>MDTraj is a robust software package that facilitates the analysis of molecular dynamics (MD) simulations by enabling the manipulation of MD trajectory data from a variety of files (<xref ref-type="bibr" rid="bib35">McGibbon et al., 2015</xref>). The package provides Python-based tools that allow for the efficient computation of structural and dynamic properties of biomolecules. In this study, MDTraj was utilized to compute several important metrics that are critical in the analysis of MD simulations. Specifically, we used MDTraj to calculate the root-mean-square-fluctuations (RMSF) and root-mean-square-deviation (RMSD) of the protein structure, hydrogen bonds, and salt bridges. RMSF quantifies the average positional fluctuation of the Cα atom of each residue during the MD simulation relative to its position in the equilibrated reference structures. RMSD quantifies the average displacement of the protein’s Cα atoms from their positions in an equilibrated reference structure. In addition, MDLovoFit was used to show the graphical representation of RMSD results (<xref ref-type="bibr" rid="bib34">Martínez, 2015</xref>). Furthermore, pairwise RMSD analyses were performed using the pytraj package, which allowed us to assess the structural similarities and differences among the conformations sampled during the simulation (<xref ref-type="bibr" rid="bib53">Roe and Cheatham, 2013</xref>). Hydrogen bonds were defined as a distance of less than 3.5 Å between a hydrogen bond donor and acceptor, with a hydrogen-donor-acceptor angle greater than 30°. Salt bridges were defined as a distance of less than 4.0 Å between a positively charged amino acid side chain (lysine or arginine) and a negatively charged side chain (aspartate or glutamate). The volume of the active-site pocket was calculated using ParkVFinder (<xref ref-type="bibr" rid="bib19">Guerra et al., 2020</xref>). Visualization of the structures of protein was performed using PyMOL (<xref ref-type="bibr" rid="bib57">Schrödinger and DeLano, 2020</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s4"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>RAB reports grants from Merck, Wockhardt, Shionogi, and Venatorx outside the submitted work</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con5"><p>Supervision, Funding acquisition, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s5"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-107688-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s6"><title>Data availability</title><p>All files required to run the simulations (topology, coordinates, input), processed trajectories (xtc), corresponding coordinates (pdb), metastable PDB files for each system described in this manuscript can be downloaded from the DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.57760/sciencedb.15876">https://doi.org/10.57760/sciencedb.15876</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Ω-Loop mutations control the dynamics of the active site by modulating a network of hydrogen bonds in PDC-3 β-lactamase</data-title><source>Science DataBank</source><pub-id pub-id-type="doi">10.57760/sciencedb.15876</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>Research reported herein was supported in part by funds the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI063517 to RAB and SH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the National Institutes of Health.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abagyan</surname><given-names>R</given-names></name><name><surname>Totrov</surname><given-names>M</given-names></name><name><surname>Kuznetsov</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation</article-title><source>Journal of Computational Chemistry</source><volume>15</volume><fpage>488</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1002/jcc.540150503</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barendregt</surname><given-names>NW</given-names></name><name><surname>Josić</surname><given-names>K</given-names></name><name><surname>Kilpatrick</surname><given-names>ZP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Analyzing dynamic decision-making models using Chapman-Kolmogorov equations</article-title><source>Journal of Computational Neuroscience</source><volume>47</volume><fpage>205</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1007/s10827-019-00733-5</pub-id><pub-id pub-id-type="pmid">31734803</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>MD</given-names></name><name><surname>Taracila</surname><given-names>MA</given-names></name><name><surname>Rutter</surname><given-names>JD</given-names></name><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Galdadas</surname><given-names>I</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Caselli</surname><given-names>E</given-names></name><name><surname>Prati</surname><given-names>F</given-names></name><name><surname>Dekker</surname><given-names>JP</given-names></name><name><surname>Papp-Wallace</surname><given-names>KM</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in <italic>Pseudomonas aeruginosa</italic></article-title><source>mBio</source><volume>9</volume><elocation-id>e02085-18</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02085-18</pub-id><pub-id pub-id-type="pmid">30538183</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattarai</surname><given-names>A</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gaussian accelerated molecular dynamics for elucidation of drug pathways</article-title><source>Expert Opinion on Drug Discovery</source><volume>13</volume><fpage>1055</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1080/17460441.2018.1538207</pub-id><pub-id pub-id-type="pmid">30371112</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornot</surname><given-names>A</given-names></name><name><surname>Etchebest</surname><given-names>C</given-names></name><name><surname>de Brevern</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Predicting protein flexibility through the prediction of local structures</article-title><source>Proteins</source><volume>79</volume><fpage>839</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1002/prot.22922</pub-id><pub-id pub-id-type="pmid">21287616</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>GR</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Using generalized ensemble simulations and Markov state models to identify conformational states</article-title><source>Methods</source><volume>49</volume><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2009.04.013</pub-id><pub-id pub-id-type="pmid">19410002</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Bruccoleri</surname><given-names>RE</given-names></name><name><surname>Olafson</surname><given-names>BD</given-names></name><name><surname>States</surname><given-names>DJ</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Karplus</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>CHARMM: A program for macromolecular energy, minimization, and dynamics calculations</article-title><source>Journal of Computational Chemistry</source><volume>4</volume><fpage>187</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1002/jcc.540040211</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Case</surname><given-names>DA</given-names></name><name><surname>Aktulga</surname><given-names>HM</given-names></name><name><surname>Belfon</surname><given-names>K</given-names></name><name><surname>Cerutti</surname><given-names>DS</given-names></name><name><surname>Cisneros</surname><given-names>GA</given-names></name><name><surname>Cruzeiro</surname><given-names>VWD</given-names></name><name><surname>Forouzesh</surname><given-names>N</given-names></name><name><surname>Giese</surname><given-names>TJ</given-names></name><name><surname>Götz</surname><given-names>AW</given-names></name><name><surname>Gohlke</surname><given-names>H</given-names></name><name><surname>Izadi</surname><given-names>S</given-names></name><name><surname>Kasavajhala</surname><given-names>K</given-names></name><name><surname>Kaymak</surname><given-names>MC</given-names></name><name><surname>King</surname><given-names>E</given-names></name><name><surname>Kurtzman</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>TS</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Luchko</surname><given-names>T</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Manathunga</surname><given-names>M</given-names></name><name><surname>Machado</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>HM</given-names></name><name><surname>O’Hearn</surname><given-names>KA</given-names></name><name><surname>Onufriev</surname><given-names>AV</given-names></name><name><surname>Pan</surname><given-names>F</given-names></name><name><surname>Pantano</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>R</given-names></name><name><surname>Rahnamoun</surname><given-names>A</given-names></name><name><surname>Risheh</surname><given-names>A</given-names></name><name><surname>Schott-Verdugo</surname><given-names>S</given-names></name><name><surname>Shajan</surname><given-names>A</given-names></name><name><surname>Swails</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Cheatham</surname><given-names>TE</given-names></name><name><surname>Roe</surname><given-names>DR</given-names></name><name><surname>Roitberg</surname><given-names>A</given-names></name><name><surname>Simmerling</surname><given-names>C</given-names></name><name><surname>York</surname><given-names>DM</given-names></name><name><surname>Nagan</surname><given-names>MC</given-names></name><name><surname>Merz</surname><given-names>KM</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2023">2023</year><article-title>AmberTools</article-title><source>Journal of Chemical Information and Modeling</source><volume>63</volume><fpage>6183</fpage><lpage>6191</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.3c01153</pub-id><pub-id pub-id-type="pmid">37805934</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerutti</surname><given-names>DS</given-names></name><name><surname>Duke</surname><given-names>RE</given-names></name><name><surname>Darden</surname><given-names>TA</given-names></name><name><surname>Lybrand</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Staggered mesh ewald: an extension of the smooth particle-mesh ewald method adding great versatility</article-title><source>Journal of Chemical Theory and Computation</source><volume>5</volume><elocation-id>2322</elocation-id><pub-id pub-id-type="doi">10.1021/ct9001015</pub-id><pub-id pub-id-type="pmid">20174456</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>SB</given-names></name><name><surname>Veve</surname><given-names>MP</given-names></name><name><surname>Wagner</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cephalosporins: a focus on side chains and β-lactam cross-reactivity</article-title><source>Pharmacy</source><volume>7</volume><elocation-id>103</elocation-id><pub-id pub-id-type="doi">10.3390/pharmacy7030103</pub-id><pub-id pub-id-type="pmid">31362351</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>McReynolds</surname><given-names>A</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Re-examining the role of Lys67 in class C beta-lactamase catalysis</article-title><source>Protein Science</source><volume>18</volume><fpage>662</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1002/pro.60</pub-id><pub-id pub-id-type="pmid">19241376</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colque</surname><given-names>CA</given-names></name><name><surname>Albarracín Orio</surname><given-names>AG</given-names></name><name><surname>Tomatis</surname><given-names>PE</given-names></name><name><surname>Dotta</surname><given-names>G</given-names></name><name><surname>Moreno</surname><given-names>DM</given-names></name><name><surname>Hedemann</surname><given-names>LG</given-names></name><name><surname>Hickman</surname><given-names>RA</given-names></name><name><surname>Sommer</surname><given-names>LM</given-names></name><name><surname>Feliziani</surname><given-names>S</given-names></name><name><surname>Moyano</surname><given-names>AJ</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>K Johansen</surname><given-names>H</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name><name><surname>Vila</surname><given-names>AJ</given-names></name><name><surname>Smania</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Longitudinal evolution of the pseudomonas-derived cephalosporinase (pdc) structure and activity in a cystic fibrosis patient treated with β-Lactams</article-title><source>mBio</source><volume>13</volume><elocation-id>e0166322</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.01663-22</pub-id><pub-id pub-id-type="pmid">36073814</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crichlow</surname><given-names>GV</given-names></name><name><surname>Kuzin</surname><given-names>AP</given-names></name><name><surname>Nukaga</surname><given-names>M</given-names></name><name><surname>Mayama</surname><given-names>K</given-names></name><name><surname>Sawai</surname><given-names>T</given-names></name><name><surname>Knox</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion</article-title><source>Biochemistry</source><volume>38</volume><fpage>10256</fpage><lpage>10261</lpage><pub-id pub-id-type="doi">10.1021/bi9908787</pub-id><pub-id pub-id-type="pmid">10441119</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crichlow</surname><given-names>GV</given-names></name><name><surname>Nukaga</surname><given-names>M</given-names></name><name><surname>Doppalapudi</surname><given-names>VR</given-names></name><name><surname>Buynak</surname><given-names>JD</given-names></name><name><surname>Knox</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone</article-title><source>Biochemistry</source><volume>40</volume><fpage>6233</fpage><lpage>6239</lpage><pub-id pub-id-type="doi">10.1021/bi010131s</pub-id><pub-id pub-id-type="pmid">11371184</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>CS</given-names></name><name><surname>Bolig</surname><given-names>T</given-names></name><name><surname>Torabi-Parizi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms and targeted therapies for <italic>Pseudomonas aeruginosa</italic> lung infection</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>197</volume><fpage>708</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1164/rccm.201705-1043SO</pub-id><pub-id pub-id-type="pmid">29087211</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doerr</surname><given-names>S</given-names></name><name><surname>Harvey</surname><given-names>MJ</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HTMD: high-throughput molecular dynamics for molecular discovery</article-title><source>Journal of Chemical Theory and Computation</source><volume>12</volume><fpage>1845</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.6b00049</pub-id><pub-id pub-id-type="pmid">26949976</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feenstra</surname><given-names>KA</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Berendsen</surname><given-names>HJC</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Improving efficiency of large time-scale molecular dynamics simulations of hydrogen-rich systems</article-title><source>Journal of Computational Chemistry</source><volume>20</volume><fpage>786</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1002/(sici)1096-987x(199906)20:83.0.Co;2-b</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golemi-Kotra</surname><given-names>D</given-names></name><name><surname>Meroueh</surname><given-names>SO</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Vakulenko</surname><given-names>SB</given-names></name><name><surname>Bulychev</surname><given-names>A</given-names></name><name><surname>Stemmler</surname><given-names>AJ</given-names></name><name><surname>Stemmler</surname><given-names>TL</given-names></name><name><surname>Mobashery</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The importance of a critical protonation state and the fate of the catalytic steps in class A beta-lactamases and penicillin-binding proteins</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>34665</fpage><lpage>34673</lpage><pub-id pub-id-type="doi">10.1074/jbc.M313143200</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>JV</given-names></name><name><surname>Ribeiro Filho</surname><given-names>HV</given-names></name><name><surname>Bortot</surname><given-names>LO</given-names></name><name><surname>Honorato</surname><given-names>RV</given-names></name><name><surname>Pereira</surname><given-names>JG</given-names></name><name><surname>Lopes-de-Oliveira</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ParKVFinder: a thread-level parallel approach in biomolecular cavity detection</article-title><source>SoftwareX</source><volume>12</volume><elocation-id>100606</elocation-id><pub-id pub-id-type="doi">10.1016/j.softx.2020.100606</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>MJ</given-names></name><name><surname>Giupponi</surname><given-names>G</given-names></name><name><surname>Fabritiis</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ACEMD: accelerating biomolecular dynamics in the microsecond time scale</article-title><source>Journal of Chemical Theory and Computation</source><volume>5</volume><fpage>1632</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1021/ct9000685</pub-id><pub-id pub-id-type="pmid">26609855</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollingsworth</surname><given-names>SA</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular dynamics simulation for all</article-title><source>Neuron</source><volume>99</volume><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id><pub-id pub-id-type="pmid">30236283</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horcajada</surname><given-names>JP</given-names></name><name><surname>Montero</surname><given-names>M</given-names></name><name><surname>Oliver</surname><given-names>A</given-names></name><name><surname>Sorlí</surname><given-names>L</given-names></name><name><surname>Luque</surname><given-names>S</given-names></name><name><surname>Gómez-Zorrilla</surname><given-names>S</given-names></name><name><surname>Benito</surname><given-names>N</given-names></name><name><surname>Grau</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epidemiology and treatment of multidrug-resistant and extensively drug-resistant infections</article-title><source>Clinical Microbiology Reviews</source><volume>32</volume><elocation-id>e00031-19</elocation-id><pub-id pub-id-type="doi">10.1128/CMR.00031-19</pub-id><pub-id pub-id-type="pmid">31462403</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husic</surname><given-names>BE</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Markov state models: from an art to a science</article-title><source>Journal of the American Chemical Society</source><volume>140</volume><fpage>2386</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1021/jacs.7b12191</pub-id><pub-id pub-id-type="pmid">29323881</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>AmpC beta-lactamases</article-title><source>Clinical Microbiology Reviews</source><volume>22</volume><fpage>161</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1128/CMR.00036-08</pub-id><pub-id pub-id-type="pmid">19136439</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurado-Martín</surname><given-names>I</given-names></name><name><surname>Sainz-Mejías</surname><given-names>M</given-names></name><name><surname>McClean</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>Pseudomonas aeruginosa</italic>: an audacious pathogen with an adaptable arsenal of virulence factors</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>3128</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22063128</pub-id><pub-id pub-id-type="pmid">33803907</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>KG</given-names></name><name><surname>Snelling</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Pseudomonas aeruginosa</italic>: a formidable and ever-present adversary</article-title><source>The Journal of Hospital Infection</source><volume>73</volume><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2009.04.020</pub-id><pub-id pub-id-type="pmid">19699552</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MO</given-names></name><name><surname>Blachly</surname><given-names>PG</given-names></name><name><surname>Kaus</surname><given-names>JW</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Protocols utilizing constant pH molecular dynamics to compute pH-dependent binding free energies</article-title><source>The Journal of Physical Chemistry. B</source><volume>119</volume><fpage>861</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1021/jp505777n</pub-id><pub-id pub-id-type="pmid">25134690</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>SD</given-names></name><name><surname>Mangani</surname><given-names>S</given-names></name><name><surname>Durand-Reville</surname><given-names>T</given-names></name><name><surname>Benvenuti</surname><given-names>M</given-names></name><name><surname>De Luca</surname><given-names>F</given-names></name><name><surname>Sanyal</surname><given-names>G</given-names></name><name><surname>Docquier</surname><given-names>J-D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and <italic>Pseudomonas aeruginosa</italic> AmpC β-lactamases</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>2496</fpage><lpage>2505</lpage><pub-id pub-id-type="doi">10.1128/AAC.02247-12</pub-id><pub-id pub-id-type="pmid">23439634</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>SD</given-names></name><name><surname>Walkup</surname><given-names>GK</given-names></name><name><surname>Whiteaker</surname><given-names>JD</given-names></name><name><surname>Palmer</surname><given-names>T</given-names></name><name><surname>McCormack</surname><given-names>K</given-names></name><name><surname>Tanudra</surname><given-names>MA</given-names></name><name><surname>Nash</surname><given-names>TJ</given-names></name><name><surname>Thresher</surname><given-names>J</given-names></name><name><surname>Johnstone</surname><given-names>MR</given-names></name><name><surname>Hajec</surname><given-names>L</given-names></name><name><surname>Livchak</surname><given-names>S</given-names></name><name><surname>McLaughlin</surname><given-names>RE</given-names></name><name><surname>Alm</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in <italic>Pseudomonas aeruginosa</italic> strains containing derepressed AmpC</article-title><source>The Journal of Antimicrobial Chemotherapy</source><volume>70</volume><fpage>1650</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1093/jac/dkv004</pub-id><pub-id pub-id-type="pmid">25645206</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>LM</given-names></name><name><surname>Silva</surname><given-names>BNM</given-names></name><name><surname>Barbosa</surname><given-names>G</given-names></name><name><surname>Barreiro</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>β-lactam antibiotics: An overview from a medicinal chemistry perspective</article-title><source>European Journal of Medicinal Chemistry</source><volume>208</volume><elocation-id>112829</elocation-id><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112829</pub-id><pub-id pub-id-type="pmid">33002736</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>AR</given-names></name><name><surname>Barnes</surname><given-names>MD</given-names></name><name><surname>Taracila</surname><given-names>MA</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Hujer</surname><given-names>KM</given-names></name><name><surname>Cabot</surname><given-names>G</given-names></name><name><surname>Feldgarden</surname><given-names>M</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Klimke</surname><given-names>W</given-names></name><name><surname>van den Akker</surname><given-names>F</given-names></name><name><surname>Vila</surname><given-names>AJ</given-names></name><name><surname>Smania</surname><given-names>A</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Papp-Wallace</surname><given-names>KM</given-names></name><name><surname>Bradford</surname><given-names>PA</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name><name><surname>Docquier</surname><given-names>J-D</given-names></name><name><surname>Frère</surname><given-names>J-M</given-names></name><name><surname>Galleni</surname><given-names>M</given-names></name><name><surname>Hanson</surname><given-names>ND</given-names></name><name><surname>Oliver</surname><given-names>A</given-names></name><name><surname>Plésiat</surname><given-names>P</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Palzkill</surname><given-names>TG</given-names></name><name><surname>Jacoby</surname><given-names>GA</given-names></name><name><surname>Bush</surname><given-names>K</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A standard numbering scheme for class C β-Lactamases</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>64</volume><elocation-id>01841-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.01841-19</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>JA</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Kasavajhala</surname><given-names>K</given-names></name><name><surname>Wickstrom</surname><given-names>L</given-names></name><name><surname>Hauser</surname><given-names>KE</given-names></name><name><surname>Simmerling</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>3696</fpage><lpage>3713</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.5b00255</pub-id><pub-id pub-id-type="pmid">26574453</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>S</given-names></name><name><surname>Hayes</surname><given-names>D</given-names></name><name><surname>Wozniak</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cystic fibrosis and <italic>Pseudomonas aeruginosa</italic>: the host-microbe interface</article-title><source>Clinical Microbiology Reviews</source><volume>32</volume><elocation-id>e00138-18</elocation-id><pub-id pub-id-type="doi">10.1128/CMR.00138-18</pub-id><pub-id pub-id-type="pmid">31142499</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0119264</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0119264</pub-id><pub-id pub-id-type="pmid">25816325</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGibbon</surname><given-names>RT</given-names></name><name><surname>Beauchamp</surname><given-names>KA</given-names></name><name><surname>Harrigan</surname><given-names>MP</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Swails</surname><given-names>JM</given-names></name><name><surname>Hernández</surname><given-names>CX</given-names></name><name><surname>Schwantes</surname><given-names>CR</given-names></name><name><surname>Wang</surname><given-names>L-P</given-names></name><name><surname>Lane</surname><given-names>TJ</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MDTraj: a modern open library for the analysis of molecular dynamics trajectories</article-title><source>Biophysical Journal</source><volume>109</volume><fpage>1528</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2015.08.015</pub-id><pub-id pub-id-type="pmid">26488642</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meroueh</surname><given-names>SO</given-names></name><name><surname>Fisher</surname><given-names>JF</given-names></name><name><surname>Schlegel</surname><given-names>HB</given-names></name><name><surname>Mobashery</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Ab initio QM/MM study of class A beta-lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70</article-title><source>Journal of the American Chemical Society</source><volume>127</volume><fpage>15397</fpage><lpage>15407</lpage><pub-id pub-id-type="doi">10.1021/ja051592u</pub-id><pub-id pub-id-type="pmid">16262403</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mongan</surname><given-names>J</given-names></name><name><surname>Case</surname><given-names>DA</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Constant pH molecular dynamics in generalized Born implicit solvent</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>2038</fpage><lpage>2048</lpage><pub-id pub-id-type="doi">10.1002/jcc.20139</pub-id><pub-id pub-id-type="pmid">15481090</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora-Ochomogo</surname><given-names>M</given-names></name><name><surname>Lohans</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates</article-title><source>RSC Medicinal Chemistry</source><volume>12</volume><fpage>1623</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1039/d1md00200g</pub-id><pub-id pub-id-type="pmid">34778765</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munita</surname><given-names>JM</given-names></name><name><surname>Arias</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mechanisms of Antibiotic Resistance</article-title><source>Microbiology Spectrum</source><volume>4</volume><elocation-id>0016-2015</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.VMBF-0016-2015</pub-id><pub-id pub-id-type="pmid">27227291</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Mammeri</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Extended-spectrum cephalosporinases: structure, detection and epidemiology</article-title><source>Future Microbiology</source><volume>2</volume><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.2217/17460913.2.3.297</pub-id><pub-id pub-id-type="pmid">17661704</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>MHM</given-names></name><name><surname>Søndergaard</surname><given-names>CR</given-names></name><name><surname>Rostkowski</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</article-title><source>Journal of Chemical Theory and Computation</source><volume>7</volume><fpage>525</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1021/ct100578z</pub-id><pub-id pub-id-type="pmid">26596171</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>Z</given-names></name><name><surname>Raudonis</surname><given-names>R</given-names></name><name><surname>Glick</surname><given-names>BR</given-names></name><name><surname>Lin</surname><given-names>TJ</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic>: mechanisms and alternative therapeutic strategies</article-title><source>Biotechnology Advances</source><volume>37</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id><pub-id pub-id-type="pmid">30500353</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Clustering algorithms to analyze molecular dynamics simulation trajectories for complex chemical and biological systems</article-title><source>Chinese Journal of Chemical Physics</source><volume>31</volume><fpage>404</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1063/1674-0068/31/cjcp1806147</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez</surname><given-names>A</given-names></name><name><surname>Herrera-Nieto</surname><given-names>P</given-names></name><name><surname>Doerr</surname><given-names>S</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>AdaptiveBandit: a multi-armed bandit framework for adaptive sampling in molecular simulations</article-title><source>Journal of Chemical Theory and Computation</source><volume>16</volume><fpage>4685</fpage><lpage>4693</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.0c00205</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Hernández</surname><given-names>G</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hierarchical time-lagged independent component analysis: computing slow modes and reaction coordinates for large molecular systems</article-title><source>Journal of Chemical Theory and Computation</source><volume>12</volume><fpage>6118</fpage><lpage>6129</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.6b00738</pub-id><pub-id pub-id-type="pmid">27792332</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Inestrosa</surname><given-names>E</given-names></name><name><surname>Suau</surname><given-names>R</given-names></name><name><surname>Montañez</surname><given-names>MI</given-names></name><name><surname>Rodriguez</surname><given-names>R</given-names></name><name><surname>Mayorga</surname><given-names>C</given-names></name><name><surname>Torres</surname><given-names>MJ</given-names></name><name><surname>Blanca</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cephalosporin chemical reactivity and its immunological implications</article-title><source>Current Opinion in Allergy and Clinical Immunology</source><volume>5</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1097/01.all.0000173788.73401.69</pub-id><pub-id pub-id-type="pmid">15985814</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippon</surname><given-names>A</given-names></name><name><surname>Arlet</surname><given-names>G</given-names></name><name><surname>Labia</surname><given-names>R</given-names></name><name><surname>Iorga</surname><given-names>BI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Class C β-lactamases: molecular characteristics</article-title><source>Clinical Microbiology Reviews</source><volume>35</volume><elocation-id>e0015021</elocation-id><pub-id pub-id-type="doi">10.1128/cmr.00150-21</pub-id><pub-id pub-id-type="pmid">35435729</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polizzi</surname><given-names>NF</given-names></name><name><surname>Therien</surname><given-names>MJ</given-names></name><name><surname>Beratan</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mean first-passage times in biology</article-title><source>Israel Journal of Chemistry</source><volume>56</volume><fpage>816</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1002/ijch.201600040</pub-id><pub-id pub-id-type="pmid">29081538</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>RA</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structure-based approach for binding site identification on AmpC beta-lactamase</article-title><source>Journal of Medicinal Chemistry</source><volume>45</volume><fpage>3222</fpage><lpage>3234</lpage><pub-id pub-id-type="doi">10.1021/jm020002p</pub-id><pub-id pub-id-type="pmid">12109906</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabantu</surname><given-names>VM</given-names></name><name><surname>Gadiyaram</surname><given-names>V</given-names></name><name><surname>Vishveshwara</surname><given-names>S</given-names></name><name><surname>Srinivasan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Understanding structural variability in proteins using protein structural networks</article-title><source>Current Research in Structural Biology</source><volume>4</volume><fpage>134</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.crstbi.2022.04.002</pub-id><pub-id pub-id-type="pmid">35586857</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>D</given-names></name><name><surname>Kollef</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The epidemiology and pathogenesis and treatment of <italic>Pseudomonas aeruginosa</italic> infections: an update</article-title><source>Drugs</source><volume>81</volume><fpage>2117</fpage><lpage>2131</lpage><pub-id pub-id-type="doi">10.1007/s40265-021-01635-6</pub-id><pub-id pub-id-type="pmid">34743315</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Martínez</surname><given-names>J-M</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>54</volume><fpage>4930</fpage><lpage>4933</lpage><pub-id pub-id-type="doi">10.1128/AAC.00427-10</pub-id><pub-id pub-id-type="pmid">20713667</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>DR</given-names></name><name><surname>Cheatham</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data</article-title><source>Journal of Chemical Theory and Computation</source><volume>9</volume><fpage>3084</fpage><lpage>3095</lpage><pub-id pub-id-type="doi">10.1021/ct400341p</pub-id><pub-id pub-id-type="pmid">26583988</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruedas-López</surname><given-names>A</given-names></name><name><surname>Alonso-García</surname><given-names>I</given-names></name><name><surname>Lasarte-Monterrubio</surname><given-names>C</given-names></name><name><surname>Guijarro-Sánchez</surname><given-names>P</given-names></name><name><surname>Gato</surname><given-names>E</given-names></name><name><surname>Vázquez-Ucha</surname><given-names>JC</given-names></name><name><surname>Vallejo</surname><given-names>JA</given-names></name><name><surname>Fraile-Ribot</surname><given-names>PA</given-names></name><name><surname>Fernández-Pérez</surname><given-names>B</given-names></name><name><surname>Velasco</surname><given-names>D</given-names></name><name><surname>Gutiérrez-Urbón</surname><given-names>JM</given-names></name><name><surname>Oviaño</surname><given-names>M</given-names></name><name><surname>Beceiro</surname><given-names>A</given-names></name><name><surname>González-Bello</surname><given-names>C</given-names></name><name><surname>Oliver</surname><given-names>A</given-names></name><name><surname>Arca-Suárez</surname><given-names>J</given-names></name><name><surname>Bou</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Selection of AmpC β-lactamase variants and metallo-β-lactamases leading to ceftolozane/Tazobactam and ceftazidime/avibactam resistance during treatment of MDR/XDR <italic>Pseudomonas aeruginosa</italic> Infections</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>66</volume><elocation-id>e0206721</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02067-21</pub-id><pub-id pub-id-type="pmid">34930034</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherer</surname><given-names>MK</given-names></name><name><surname>Trendelkamp-Schroer</surname><given-names>B</given-names></name><name><surname>Paul</surname><given-names>F</given-names></name><name><surname>Pérez-Hernández</surname><given-names>G</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Plattner</surname><given-names>N</given-names></name><name><surname>Wehmeyer</surname><given-names>C</given-names></name><name><surname>Prinz</surname><given-names>J-H</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PyEMMA 2: a software package for estimation, validation, and analysis of markov models</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>5525</fpage><lpage>5542</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.5b00743</pub-id><pub-id pub-id-type="pmid">26574340</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlegel</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Optimization of equilibrium geometries and transition structures</article-title><source>Journal of Computational Chemistry</source><volume>3</volume><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1002/jcc.540030212</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Schrödinger</surname><given-names>L</given-names></name><name><surname>DeLano</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>PyMOL</article-title><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/pymol">http://www.pymol.org/pymol</ext-link><date-in-citation iso-8601-date="2023-11-21">November 21, 2023</date-in-citation></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Meroueh</surname><given-names>SO</given-names></name><name><surname>Fisher</surname><given-names>JF</given-names></name><name><surname>Mobashery</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Investigation of the mechanism of the cell wall DD-carboxypeptidase reaction of penicillin-binding protein 5 of <italic>Escherichia coli</italic> by quantum mechanics/molecular mechanics calculations</article-title><source>Journal of the American Chemical Society</source><volume>130</volume><fpage>9293</fpage><lpage>9303</lpage><pub-id pub-id-type="doi">10.1021/ja801727k</pub-id><pub-id pub-id-type="pmid">18576637</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spagnolo</surname><given-names>AM</given-names></name><name><surname>Sartini</surname><given-names>M</given-names></name><name><surname>Cristina</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>Pseudomonas aeruginosa</italic> in the healthcare facility setting</article-title><source>Reviews in Medical Microbiology</source><volume>32</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1097/MRM.0000000000000271</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tacconelli</surname><given-names>E</given-names></name><name><surname>Carrara</surname><given-names>E</given-names></name><name><surname>Savoldi</surname><given-names>A</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Monnet</surname><given-names>DL</given-names></name><name><surname>Pulcini</surname><given-names>C</given-names></name><name><surname>Kahlmeter</surname><given-names>G</given-names></name><name><surname>Kluytmans</surname><given-names>J</given-names></name><name><surname>Carmeli</surname><given-names>Y</given-names></name><name><surname>Ouellette</surname><given-names>M</given-names></name><name><surname>Outterson</surname><given-names>K</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><name><surname>Cavaleri</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>EM</given-names></name><name><surname>Houchens</surname><given-names>CR</given-names></name><name><surname>Grayson</surname><given-names>ML</given-names></name><name><surname>Hansen</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Theuretzbacher</surname><given-names>U</given-names></name><name><surname>Magrini</surname><given-names>N</given-names></name><collab>WHO Pathogens Priority List Working Group</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title><source>The Lancet. Infectious Diseases</source><volume>18</volume><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id><pub-id pub-id-type="pmid">29276051</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trendelkamp-Schroer</surname><given-names>B</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Efficient Bayesian estimation of Markov model transition matrices with given stationary distribution</article-title><source>The Journal of Chemical Physics</source><volume>138</volume><elocation-id>164113</elocation-id><pub-id pub-id-type="doi">10.1063/1.4801325</pub-id><pub-id pub-id-type="pmid">23635117</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>R</given-names></name><name><surname>Nair</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanism of acyl-enzyme complex formation from the Henry-Michaelis complex of class C β-lactamases with β-lactam antibiotics</article-title><source>Journal of the American Chemical Society</source><volume>135</volume><fpage>14679</fpage><lpage>14690</lpage><pub-id pub-id-type="doi">10.1021/ja405319n</pub-id><pub-id pub-id-type="pmid">24010547</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>R</given-names></name><name><surname>Nair</surname><given-names>NN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deacylation mechanism and kinetics of acyl-enzyme complex of class C β-Lactamase and cephalothin</article-title><source>The Journal of Physical Chemistry. B</source><volume>120</volume><fpage>2681</fpage><lpage>2690</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.5b11623</pub-id><pub-id pub-id-type="pmid">26918257</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Meroueh</surname><given-names>SO</given-names></name><name><surname>Vakulenko</surname><given-names>SB</given-names></name><name><surname>Mobashery</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Catalytic mechanism of penicillin-binding protein 5 of <italic>Escherichia coli</italic></article-title><source>Biochemistry</source><volume>46</volume><fpage>10113</fpage><lpage>10121</lpage><pub-id pub-id-type="doi">10.1021/bi700777x</pub-id><pub-id pub-id-type="pmid">17685588</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107688.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Allen</surname><given-names>Toby W</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>RMIT University</institution><country>Australia</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Incomplete</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This article uses adaptive-bandit simulations to describe the dynamics of the <italic>Pseudomonas</italic>-derived chephalosporinase PDC-3 β-lactamase and its mutants to better understand antibiotic resistance. The finding that clinically observed mutations alter the flexibility of the Ω- and R2-loops, reshaping the cavity of the active site, is <bold>valuable</bold> to the field. The evidence is considered <bold>incomplete</bold>, however, with the need for analysis to demonstrate equilibrium weighting of adaptive trajectories and related measures of statistical significance.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107688.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics 2 of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived chephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author conclude that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds in disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67 and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent componente analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p><p>Strengths:</p><p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem and, in particular, <italic>Pseudomonas aeruginosa</italic> resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript that this simulation strategy is well suited for the problem under evaluation.</p><p>Weaknesses:</p><p>In the revised version, the authors addressed my concerns regarding their use of the MSM, and in my view, their conclusions are now much more robust and well-supported by the data. While it would be very interesting to see a quantitative correlation between the effects of the mutations observed in the MD data and relevant experimental findings, I understand that this may be beyond the scope of the manuscript.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107688.3.sa2</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting and the study uses MD simulations and to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. Some greater consideration of the uncertainties and how the method choice affect the ability to compare equilibrium properties would strengthen the quantitative conclusions. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p><p>Strengths:</p><p>The significance of the problem is clearly described the relationship to prior literature is discussed extensively.</p><p>Comments on revised version:</p><p>I am concerned that the authors state in the response to reviews that it is not possible to get error bars on values due to the use of the AB-MD protocol that guides the simulations to unexplored basins. Yet the authors want to compare these values between the WT and mutants. This relates to RMSD, RMSF, % H-bond and volume calculations. I don't accept that you cannot calculate an uncertainty on a time averaged property calculated across the entire simulation. In these cases you can either run repeat simulations to get multiple values on which to do statistical analysis, or you can break the simulation into blocks and check both convergence and calculate uncertainties.</p><p>I note that the authors do provide error bars on the volumes, but the statistics given for these need closer scrutiny (I cant test this without the raw data). For example the authors have p&lt;0.0001 for the following pair of volumes 1072 {plus minus} 158 and 1115 {plus minus} 242, or for SASA p&lt;0.0001 is given for 2 identical numbers 155+/- 3.</p><p>I also remain concerned about comparisons between simulations run with the AB-MD scheme. While each simulation is an equilibrium simulation run without biasing forces, new simulations are seeded to expand the conformational sampling of the system. This means that by definition the ensemble of simulations does not represent and equilibrium ensemble. For example, the frequency at which conformations are sampled would not be the same as in a single much longer equilibrium simulation. While you may be able to see trends in the differences between conditions run in this way, I still don't understand how you can compare quantitative information without some method of reweighing the ensemble. It is not clear that such a rewieghting exists for this methods, in which case I advise some more caution in the wording of the comparisons made from this data.</p><p>At this stage I don't feel the revision has directly addressed the main comments I raised in the earlier review, although there is a stronger response to the comments of Reviewer #2.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107688.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shuang</given-names></name><role specific-use="author">Author</role><aff><institution>University College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Mack</surname><given-names>Andrew R</given-names></name><role specific-use="author">Author</role><aff><institution>Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hujer</surname><given-names>Andrea M</given-names></name><role specific-use="author">Author</role><aff><institution>Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bethel</surname><given-names>Christopher R</given-names></name><role specific-use="author">Author</role><aff><institution>Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bonomo</surname><given-names>Robert A</given-names></name><role specific-use="author">Author</role><aff><institution>Case Western Reserve University</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><role specific-use="author">Author</role><aff><institution>University College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the current reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics 2 of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived chephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author conclude that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds in disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67 and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent componente analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p><p>Strengths:</p><p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem and, in particular, <italic>Pseudomonas aeruginosa</italic> resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript that this simulation strategy is well suited for the problem under evaluation.</p><p>Weaknesses:</p><p>In the revised version, the authors addressed my concerns regarding their use of the MSM, and in my view, their conclusions are now much more robust and well-supported by the data. While it would be very interesting to see a quantitative correlation between the effects of the mutations observed in the MD data and relevant experimental findings, I understand that this may be beyond the scope of the manuscript.</p></disp-quote><p>Thank you for the careful evaluation and constructive comments. Regarding the suggestion of a more quantitative correlation with experimental observables, we agree that this would be valuable, and we have noted it as an important direction for future work.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting and the study uses MD simulations and to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. Some greater consideration of the uncertainties and how the method choice affect the ability to compare equilibrium properties would strengthen the quantitative conclusions. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p><p>Strengths:</p><p>The significance of the problem is clearly described the relationship to prior literature is discussed extensively.</p><p>Comments on revised version:</p><p>I am concerned that the authors state in the response to reviews that it is not possible to get error bars on values due to the use of the AB-MD protocol that guides the simulations to unexplored basins. Yet the authors want to compare these values between the WT and mutants. This relates to RMSD, RMSF, % H-bond and volume calculations. I don't accept that you cannot calculate an uncertainty on a time averaged property calculated across the entire simulation. In these cases you can either run repeat simulations to get multiple values on which to do statistical analysis, or you can break the simulation into blocks and check both convergence and calculate uncertainties.</p></disp-quote><p>We thank the reviewer for raising this point. We would like to clarify that we did not intend to state that error bars are impossible to obtain under AB-MD. In fact, we reported error bars for several quantities derived from the AB-MD trajectories (we also broke the trajectories into blocks and calculated uncertainties for RMSF in our first-round response as you suggested). However, these data are closely related to your concern about comparing quantitative information without an appropriate reweighting of the ensemble. Therefore, in the revised manuscript, we removed quantitative analyses that were calculated directly from the raw AB-MD trajectories. Instead, the quantitative comparisons are now obtained from MSM analysis. We report pocket volumes and key interaction metrics for MSM metastable states, with corresponding error bars for these MSM-based quantities (Figure 6 and its supplementary figure).</p><disp-quote content-type="editor-comment"><p>I note that the authors do provide error bars on the volumes, but the statistics given for these need closer scrutiny (I cant test this without the raw data). For example the authors have p&lt;0.0001 for the following pair of volumes 1072 {plus minus} 158 and 1115 {plus minus} 242, or for SASA p&lt;0.0001 is given for 2 identical numbers 155+/- 3.</p></disp-quote><p>Thank you for this comment. As noted above, we have removed the table from the manuscript, and the pocket-volume results together with their error bars are now shown in Figure 6. To address the concern raised here and to avoid making the same mistake in future analyses, we re-examined how the statistics were computed. We believe the very small p-values were caused by treating per-frame MD values as independent observations in two-sample t-tests. Because consecutive MD frames are strongly time-correlated, they do not satisfy the independence assumption, which can greatly overestimate the effective sample size and lead to artificially small p-values. For the SASA, a p &lt; 0.0001 is reported even though both values are shown as 155 ± 3. This is due to rounding, which can hide subtle underlying differences.</p><disp-quote content-type="editor-comment"><p>I also remain concerned about comparisons between simulations run with the AB-MD scheme. While each simulation is an equilibrium simulation run without biasing forces, new simulations are seeded to expand the conformational sampling of the system. This means that by definition the ensemble of simulations does not represent and equilibrium ensemble. For example, the frequency at which conformations are sampled would not be the same as in a single much longer equilibrium simulation. While you may be able to see trends in the differences between conditions run in this way, I still don't understand how you can compare quantitative information without some method of reweighing the ensemble. It is not clear that such a rewieghting exists for this methods, in which case I advise some more caution in the wording of the comparisons made from this data.</p><p>At this stage I don't feel the revision has directly addressed the main comments I raised in the earlier review, although there is a stronger response to the comments of Reviewer #2.</p></disp-quote><p>We thank the reviewer for reiterating this important point, and we agree with the underlying concern. Although AB-MD generates unbiased trajectories, the ensemble of simulations does not represent an equilibrium ensemble. As a result, statistics computed by simply concatenating all AB-MD trajectories should not be used for quantitative comparisons. In the original version, we acknowledge that we reported several quantitative descriptors directly from concatenated AB-MD frames, including (i) distributions of χ1 torsions, (ii) mean pocket volumes and SASA, and (iii) percentages of some key interactions. We agree that this was not appropriate given the adaptive sampling protocol. In the revised manuscript, we have removed these quantitative analyses.</p><p>We retained RMSD and RMSF analyses, but we have revised their wording and clarified their purpose. RMSD and RMSF are used only to summarize the structural variability and residue-level mobility observed across the collected trajectory segments and to motivate the selection of structural features for MSM construction. The manuscript now states: “Because AB-MD adaptively seeds new unbiased trajectories to expand conformational sampling, RMSD and RMSF are used here to summarize the structural variability and per-residue mobility observed across the collected trajectories.”</p><p>Regarding the reviewer’s question about reweighting, the Markov state model (MSM) provides a principled framework to obtain the stationary distribution <italic>π</italic> from the transition probability matrix <italic>Tτ</italic>. The resulting <italic>πi</italic> gives the equilibrium weight of each microstate <italic>i</italic>, and the corresponding discrete free energy can be written as <italic>Fi</italic>=−<italic>k</italic><sub>B</sub><italic>T</italic>ln(<italic>πi</italic>). PCCA then coarse-grains the microstate space into a small number of metastable states. In the revised manuscript, quantitative comparisons are therefore derived from the MSM at the level of these metastable states, rather than from unweighted counts of concatenated AB-MD frames.</p><p>Accordingly, we have revised the sections “E219K and Y221A mutations facilitate proton transfer” and “Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams”, and we have added new figures in Figure 6 and its figure supplement. The adjustments to the quantitative analyses do not affect our original conclusions.</p><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1</bold> (<bold>Public review)</bold>:</p><p>Summary:</p><p>This manuscript uses adaptive sampling simulations to understand the impact of mutations on the specificity of the enzyme PDC-3 β-lactamase. The authors argue that mutations in the Ω-loop can expand the active site to accommodate larger substrates.</p><p>Strengths:</p><p>The authors simulate an array of variants and perform numerous analyses to support their conclusions. The use of constant pH simulations to connect structural differences with likely functional outcomes is a strength.</p><p>Weaknesses:</p><p>I would like to have seen more error bars on quantities reported (e.g., % populations reported in the text and Table 1).</p></disp-quote><p>We appreciate this point. Here, the population we analyze is intended to showcase conformational differences across variants rather than to estimate equilibrium occupancies. Although each system includes 100 trajectories, they were generated using an adaptive-bandit protocol. The protocol deliberately guides towards underexplored basins, therefore conformational heterogeneity betweentrajectories is expected by design. For example, in E219K the MSM decomposition shows that in states 1, 6, and 7 the K67(NZ)–S64(OG) distance is almost entirely &gt; 6 Å, whereas in states 2 and 3 it is almost entirely &lt; 3.5 Å (Figure 5—figure supplement 12). These distances suggest that the hydrogen bond fraction is approximately zero in states 1, 6, and 7, and close to one in states 2 and 3. In addition, the mean first passage time of the Markov state models suggests that the formation and disruption of this hydrogen bond occur on the microsecond timescale, which is far longer than the length of each individual trajectory (300 ns). Consequently, across the 100 replicas, some trajectories exhibit very low fractions, while others display the opposite trend. Under such bimodal, protocol-induced heterogeneity, computing an error bar across trajectories mainly visualizes the protocol’s dispersion and risks being misread as thermodynamic uncertainty, which is not central to our aim of comparing conformational differences between wild-type PDC-3 and variants. We therefore do not include the error bars.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2</bold> (<bold>Public review)</bold>:</p><p>Summary:</p><p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived cephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author concludes that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds is disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67, and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent component analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p><p>Strengths:</p><p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem, and, in particular, <italic>Pseudomonas aeruginosa</italic> resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript suggests that this simulation strategy is well-suited for the problem under evaluation.</p><p>Weaknesses:</p><p>In the description of many of their results, the authors do not provide enough information for a deep understanding of the biochemistry/biophysics involved. Without these issues addressed, the strength of the evidence is of concern.</p></disp-quote><p>We thank the reviewer for pointing out the need for deeper discussion of the biochemical and biophysical implications of our results. In our manuscript, we begin by examining basic structural metrics (e.g., RMSD and RMSF) which clearly indicate that the major conformational changes occur in the Ω-loop and the R2 loop. We have now added a paragraph to describe the importance of the Ωloop and highlighted it in the revised manuscript on lines 142-166 of page 6. This observation guided our subsequent focus on these regions, as well as on the catalytic site. Our analysis revealed notable alterations in the hydrogen bonding network—especially in interactions involving the K67-S64, K67N152, K67-G220, Y150-A292, and N287-N314 pairs. These observations led us to conclude that:</p><p>(1) Mutations E219K and Y221A facilitate the proton transfer of catalytic residues. This is consistent with prior experimental data showing that these substitutions produce the most pronounced increase in sensitivity to cephalosporin antibiotics (lines 210-212 in page 8 of the revised manuscript).</p><p>(2) Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams.This is in line with MIC measurements reported by Barnes et al. (2018), which showed that mutants with larger active-site pockets exhibit markedly greater sensitivity to cephalosporins with bulky side chains than others (lines 249-259 in pages 10).</p><p>Furthermore, we applied Markov state models (MSMs) to explore the timescales of the transitions between these different conformational states. We believe that these methodological steps support our conclusions.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3</bold> (<bold>Public review)</bold>:</p><p>Summary:</p><p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting, and the study uses MD simulations to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. However, the study doesn't clearly describe the way the data is generated. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p><p>Strengths:</p><p>The significance of the problem is clearly described, and the relationship to prior literature is discussed extensively.</p><p>Weaknesses:</p><p>The methods used to gain the results are not explained clearly, meaning it was hard to determine exactly how some data was obtained. The convergence and uncertainties in the data were not adequately quantified. The text is also a little long, which obscures the main findings.</p></disp-quote><p>We thank the reviewer for the suggestion. We respectfully ask the reviewer to specify which aspects of the data-generation methods are unclear so that we can include the necessary details in the next revision. Moreover, all statistics that are reported in the manuscript are obtained from extensive analyses of 300,000 simulation frames. The Markov state models have been validated by the ITS plots and Chapman-Kolmogorov (CK) test. The two-sample t-tests were also carried out for the volume and SASA.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors)</bold>:</p><p>(1) Figure 1D focus on the PDC3 catalytic site. However, the authors mentioned before that the enzyme has two domains, an alpha domain and an alpha/beta domain. The reader would benefit from a more detailed description of the enzyme, its active site, AND the location of the mutants under investigation in the figure.</p></disp-quote><p>We have updated Figure 1D and marked the positions of all mutations (V211A/G, G214A/R, E219A/G/K and Y221A/H), which have now been highlighted as spheres.</p><disp-quote content-type="editor-comment"><p>(2) Since in the journal format, the results come before the methods. It would be interesting to add a brief description of where the results came from. For example, in the first section of the results, the authors describe the flexibility of the omega loop and the R2 loop. However, the reader won't know what kind of simulation was used and for how long, for example. A sentence would add the required context for a deeper understanding here.</p></disp-quote><p>At the beginning of the Results and Discussion section we now state: “To investigate how the mutations in the Ω-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 μs per system) were run.”</p><disp-quote content-type="editor-comment"><p>(3) Still in the same section, the authors don't define what change in RMSF is considered significant. For example, I can't see a relevant change in the RMSF for the omega loop between the et enzyme and the E219 mutants in Figure 2D. A more objective definition would be of benefit here.</p></disp-quote><p>Our analysis reveals that while the wild-type PDC-3 and the G214A, G214R, E214G, and Y221A variants exhibit an average per-residue RMSF of around 4 Å in the Ω-loop, the V211A and V211G variants show markedly lower values (around 1.5 Å), and the E219K and Y221H variants exhibit intermediate values between 2 and 2.5 Å. In addition, the fluctuations around the binding site should be seen collectively along with the fluctuations in the R2-loop. Importantly, we urge the reviewer to focus on the MDLovofit analysis in Figure 2C, where the dynamic differences between the core and the fluctuating loops is clearly evident.</p><disp-quote content-type="editor-comment"><p>(4) In line 138, the authors state that &quot;Therefore, the flexibility of these proteins is mainly caused by the fluctuations in the Ω-loops and R2-loop&quot;. This is quite a bold statement to be drawn at this point. First of all, there is no mention of it in the manuscript, but is there any domain movement? Figure 2C clearly shows that there is some mobility in omega and R2 loops. But there is no evidence shown in the manuscript that shows that &quot;the flexibility of these proteins is mainly caused by the fluctuations in the&quot; loops. Please consider rephrasing this sentence or adding more data, if available.</p></disp-quote><p>We have revised the wording to take the reviewer’s concern into account. The sentence now states: “Therefore, flexibility of PDC-3 is predominantly localized to the Ω- and R2-loops, whereas the remainder of the structure is comparatively rigid.” To further explain to the reviewer, the β lactamase enzymes are fairly rigid structures, where no large-scale domain motions occur. Instead, the enzyme communicates structurally via cross correlation of loop dynamics (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.66567">https://doi.org/10.7554/eLife.66567</ext-link>).</p><disp-quote content-type="editor-comment"><p>(5) I guess, the most relevant question for the scope of the paper is not answered in this section. The authors show that the mobility of the omega- and R2-loops is altered by some mutations. Why is that? I wish I could see a figure showing where the mutations are and where the loops are. This question will come back in other sections.</p></disp-quote><p>We have updated Figure 1D to mark the positions of all mutations (V211A/G, G214A/R, E219A/G/K and Y221A/H) as spheres. The Ω- and R2-loops are also highlighted. All mutations map to the Ω-loop, indicating that these substitutions directly perturb this region. Notably, K67 forms a hydrogen bond with the backbone of G220 within the Ω-loop and another with the phenolic hydroxyl of Y150. Y150, in turn, hydrogen-bonds with A292 in the R2 loop. Together, the residue interaction network (G220– K67–Y150–A292) suggest a pathway by which Ω-loop mutations propagate their effects to the R2 loop.</p><disp-quote content-type="editor-comment"><p>(6) The authors then analyze the network of polar residues in the active site and the hydrogen bonds observed there. For the K67-N152 hydrogen bond, for example, there is a reduction in the occupancy from ~70% in the wild-type enzyme to ~30% and 40% in the mutants E219K and Y221, respectively. This finding is interesting. The question that remains is &quot;why is that&quot;? From the structural point of view, how does the replacement of E219 with a Lysine alter the hydrogen bond formation between K67 and N152? Is it due to direct competition? Solvent rearrangement? The reader is left without a clue in this section. Also, Figure 3B won't help the reader, since the mutated residues are not shown there. Please consider adding some information about why the authors believe that the mutations are disrupting the active site hydrogen bond network and showing it in Figure 3B.</p></disp-quote><p>We appreciate the comment and have updated Figures 1D and 3B to highlight the mutation sites. The change from ~70% in the wild type to ~30–40% in the E219K and Y221T variants reported in Table 1 refers to the S64–K67 hydrogen bond. In the wild type, K67 forms an additional hydrogen bond with G220 on the Ω-loop, which helps anchor the K67 side chain in a geometry that favors the S64–K67 interaction. In the variants, the mutations reshape the Ω-loop and frequently disrupt the K67–G220 contact. The loss of this local anchor increases the conformational dispersion of K67, which is consistent with the observed reduction of the S64–K67 occupancy. Furthermore, our observation that the mutations are disrupting the active-site hydrogen-bond network is a data-driven conclusion rather than a subjective inference. Across ten systems, our AB-MD simulations provided 30 µs of sampling per system. Saving one frame every nanosecond yielded 30,000 conformations per system and 300,000 in total. All hydrogen-bond and salt-bridge statistics were computed over this full ensemble. Thus, the conclusion that the mutations disrupt the active-site hydrogen-bond network follows directly from these ensemble statistics.</p><disp-quote content-type="editor-comment"><p>(7) The pKa calculations and the pocket volume calculations show that the mutations expand the volume of the catalytic site and alter the microenvironment. Is there any change in the solvation associated with these changes? If the volume expands and the environment becomes more acidic, are there more water molecules in the mutants as compared to the wt enzyme? If so, can changes in solvation be associated with the changes in the hydrogen bond network? Would a simulation in the presence of a substrate be meaningful here? (I guess it would!).</p></disp-quote><p>Regarding solvation, we observe a modest increase in transient water occupancy associated with the increase in volume of the pocket. The conserved deacylation water molecule is the most important and is always present throughout the simulation. Additional waters enter and leave the pocket but do not form persistent interactions that measurably perturb the hydrogen-bond network of the Ω- and R2-loops. We agree that simulations with a bound substrate would be informative. However, our study focuses on how Ω-loop mutations modulate the active site of apo PDC-3 and its variants. Within this scope, we find: (i) Amino acid substitutions change the flexibility of Ω-loops and R2-loops; (ii) E219K and Y221A mutations facilitate the proton transfer; (iii) Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams.</p><disp-quote content-type="editor-comment"><p>(8) I have some concerns regarding the Markov State Modeling as shown here. After a time-independent component analysis, the authors show the projections on the components, which is different between wild wild-type enzyme and the mutants, and draw some conclusions from these changes. For example, the authors state that &quot;From the metastable state results, we observe that E219K adopts a highly stable conformation in which all the tridentate hydrogen-bonding interactions (K67(NZ)-S64(OG), K67(NZ)N152(OD1) and K67(NZ)-G220(O)) mentioned above are broken&quot;. This is conclusion is very difficult to draw from Figure 5 alone. Unless the macrostates observed in the MSM can be shown (their structures) and could confirm the broken interactions, I really don't believe that the reader can come to the same conclusion as drawn by the authors here. I would recommend the authors to map the macrostates back to the coordinates and show them (what structure corresponds to what macrostate). After showing that, it makes sense to discuss what macrostate is being favored by what mutation. Taking conclusions from tiCA projections only is not recommended. I very strongly suggest that the authors revisit this entire section, adding more context so that the reader can draw conclusions from the data that is shown.</p></disp-quote><p>We appreciate the reviewer’s concern. In the Markov state modeling section, our objective is to quantify the timescales (via mean first passage times) associated with the formation and disruption of the critical hydrogen bonds (K67(NZ)-S64(OG), K67(NZ)-N152(OD1), K67(NZ)-G220(O), Y150(N)A292(O), N287(ND2)-N314(OD1)) mentioned above. Representative structures illustrating these interactions are shown in Figures 3B and 4A. We agree that the main Figure 5 alone does not convey structural information. Accordingly, we provide Figure 5—figure supplements 12–16. Together, Figure 5B and Figure 5—figure supplements 12–16 map structures to metastable states, whereas Figures 3B and 4A supply atomistic detail of the interactions. Author response image 1 presents selected subplots from Figure 5— figure supplements 12–14. Together with the free-energy landscape in Figure 5A, these data indicate that E219K adopts a highly stable conformation in which all three K67-centered hydrogen bonds (K67(NZ)–S64(OG), K67(NZ)–N152(OD1), and K67(NZ)–G220(O)) are broken.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><caption><title>TICA plot illustrates the distribution of E219K with the colour indicating the K67(NZ)-S64(OG), K67(NZ)-N152(OD1) and K67(NZ)-G220(O) distance.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-sa3-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>(9) As a very minor issue, there are a few typos in the manuscript text. The authors might want to take some time to revisit their entire text. Examples in lines 70, 197, etc.</p></disp-quote><p>Thank you for your comment. We have corrected these typos.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors)</bold>:</p><p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting, and the study uses MD simulations to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket.</p><p>However, the study doesn't clearly describe the way the data is generated and potentially lacks statistical rigour, which makes it uncertain if the key results are significant. As such, it is difficult to judge if the conclusions made are supported by data.</p></disp-quote><p>All necessary data-acquisition methods are described in the Methods section. The Markov state models have been validated by the ITS plot and the Chapman-Kolmogorov (CK) test (Figure 5—figure supplement 2–11) . The two-sample t-tests were also carried out for the volume and SASA (Table 2).</p><disp-quote content-type="editor-comment"><p>The results section jumps straight to reporting RMSD and RMSF values; however, it is not clear what simulations are used to generate this information. Indeed, the main text does not mention the simulations themselves at all. The methods section mentions that 10 independent MD simulations were set up for each system, but no information is given as to how long these were run or the equilibration protocol used. Then it says that AB-MD simulations were run, but it is not clear what starting coordinates were used for this or how the 10 replicates were fed into these simulations. Most importantly, are the RMSD and RMSF calculations and later distance distribution information derived from the equilibrium MD runs or from the AB-MD simulations?</p></disp-quote><p>Thank you for pointing this out. We have added “To investigate how the mutations in the Ω-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 μs per system) were run.” to the Results and Discussion section. We didn’t run 10 independent MD simulations per system. We regret the typo in the Methods section that confused the reviewer. The sentence should have read – ‘All-atom MD simulations of wild-type PDC-3 and its variants were performed.’ Each system was equilibrated for 5 ns at 1 atmospheric pressure using Berendsen barostat. AB-MD simulations were initiated from these equilibrated structures. All analyses, apart from CpHMD, are based on the AB-MD trajectories.</p><disp-quote content-type="editor-comment"><p>If these are taken from the equilibrium simulations, then it is critical that the reproducibility and statistical significance of the simulations is established. This can be done by calculating the RMSD and RMSF values independently for each replicate and determining the error bars. From this, the significance of differences between WT and mutant simulations can be determined. Without this, I have no data to judge if the main conclusions are supported or not. If these are derived from the AB-MD simulations, then I want to know how the independent simulations were combined and reweighted to generate overall RMSD, RMSF, and distance distributions. Unless I misunderstand the approach, the individual simulations no longer sample all regions of conformational space the same relative amount you would see in a standard MD simulation - specific conformational regions are intentionally run more to enhance sampling, then the overall conformational distributions cannot be obtained from these simulations without some form of reweighting scheme. But no such scheme is described. In addition, convergence of the data is required to ensure that the RMSD, RMSF, and distances have reached stable values. It is possible that I am misunderstanding the approach here. But in that case, I hope the authors can clarify the method and provide a means of ensuring that the data presented is converged. Many of the differences are clear by eye, but it is important to know they are not random differences between simulations and rather reflect differences between them.</p></disp-quote><p>Thank you for raising this important point. In our AB-MD workflow, the adaptive bandit is used only for starting-structure selection (adaptive seeding). After each epoch, it chooses new starting snapshots from previously sampled conformations and launches the next runs. Each trajectory itself is standard, unbiased MD with no biasing potentials and no modification of the Hamiltonian. In other words, AB decides where we start, but does not alter the physics or sampling dynamics within an individual trajectory. In addition, our goal in this work is to compare variants under the same adaptive-bandit (AB) protocol, rather than to estimate equilibrium (Boltzmann) populations. Hence, we did not apply equilibrium reweighting to RMSD, RMSF, or distance distributions. However, MSM section provides reweighted reference results based on the MSM stationary distribution.</p><disp-quote content-type="editor-comment"><p>In the response to reviews, the authors state that the &quot;RMSF is a statistical quantity derived from averaging the time series of atomic displacements, resulting in a fixed value without an inherent error bar.&quot; But normally we would run multiple replicates and get an error bar from the different values in each. To dismiss the request for uncertainties and error bars seems to miss the point. I strongly agree with the prior reviewer that comparisons between RMSF or other values should be accompanied by uncertainties and estimates of statistical significance.</p></disp-quote><p>Regarding the reviewers’ suggestion to present the data as a bar graph with error bars, we would like to note that RMSF is calculated as the time average of the fluctuations of each residue’s Cα atom over the entire simulation. As such, RMSF is a statistical quantity derived from averaging the time series of atomic displacements, resulting in a fixed value without an inherent error bar. We believe that our current presentation clearly and accurately reflects the local flexibility differences among the variants. Nearly all published studies report RMSF in this way, as indicated by the following examples:</p><p>Figure 3a in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jacsau.2c00077">https://doi.org/10.1021/jacsau.2c00077</ext-link></p><p>Figure 2 in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jcim.4c00089">https://doi.org/10.1021/acs.jcim.4c00089</ext-link></p><p>Supplementary Fig. 1, 2, 5, 9, 12, 20, 22, 24, and 26 in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-022-293313">https://doi.org/10.1038/s41467-022-293313</ext-link></p><p>However, in response to the reviewers’ strong request, we present RMSF plots with error bars in our response letter.</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><caption><title>The root-mean-square fluctuation (RMSF) profiles of wild-type PDC-3 and its variants.</title><p>Blue lines show the mean RMSF across 100 independent MD trajectories for each system; red translucent bands denote the standard deviation across trajectories. The Ω-loop (residues G183 to S226) is highlighted in yellow, and the R2-loop (residues L280 to Q310) is highlighted in blue.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107688-sa3-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>It was good to see that convergence of the constant-pH simulations was shown. While it can be challenging to get absolute pH values from the implicit solvent-based simulations, the differences between the systems are large and the trends appear significant. I was not clear how the starting coordinates were chosen for these simulations. Is the end point of the classical simulations, or is a representative snapshot chosen somehow?</p></disp-quote><p>To ensure comparison, all systems used the X-ray crystal structure (PDB ID: 4HEF) with T79A substitution as the initial structure. The E219K and Y221A mutants were generated in silico using the ICM mutagenesis module. We have added the clarification in Methods section: “The starting structures were identical to those used for AB-MD.”</p><disp-quote content-type="editor-comment"><p>Significant figures: Throughout the text and tables, the authors present data with more figures than are significant. 1071.81+-157.55 should be reported as 1100 +/ 160 or 1070 =- 160 . See the eLife guidelines for advice on this.</p></disp-quote><p>Thank you for your suggestion. We have amended these now.</p><disp-quote content-type="editor-comment"><p>The manuscript is very long for the results presented, and I feel that a clearer story would come across if the authors shortened the text so that the main conclusions and results were not lost.</p></disp-quote><p>We appreciate the suggestion. We examined the twenty most recent research articles published in eLife and found that they are either longer than or comparable in length to our manuscript.</p></body></sub-article></article>